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ABSTRACT
Mechanisms of environmental carcinogenesis and metal-induced cellular signaling.
Jacquelyn Jo Bower
Low dose chronic exposure to environmental carcinogens is a major cause of
human cancers. More than 375 known or suspected environmental carcinogens have
been identified, many of which are transition metals or metal containing compounds
(IARC, updated to 2004, http://www-cie.iarc.fr/monoeval/crthall.html). Although much
research has focused on the ability of these metals to induce reactive oxygen species
formation (ROS), DNA damage, and apoptosis, less effort has been put forth to examine
the cellular signaling mechanisms responsible for these effects.

Our experimental

research has focused on the signaling pathways induced in response to arsenic exposure.
Arsenic is a highly interesting transition metal due to its widespread exposure and
paradoxic ability to induce carcinogenesis as well as apoptosis. Here, we highlight the
importance of the human genome project in advancing the knowledge of the molecular
mechanisms of metal-induced toxicology/carcinogenesis. In addition, we review the
latest research in the field of metal-induced carcinogenesis.

Finally, we describe a

mechanism for the induction of the growth-arrest and DNA damage inducible protein 45
alpha (GADD45α) involving arsenic-induced ROS formation in the non-tumorigenic
human lung airway epithelial cell line, BEAS-2B.
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SECTION I: OVERVIEW

1

Arsenic
Arsenic is a ubiquitous environmental contaminant found in food, water, cigarette
smoke, soil, pesticides, and wood preservatives; thus, exposure can occur through dermal
contact, inhalation, ingestion, and occupational routes (1-8).
health

effects,

including

hyperkeratosis,

A multitude of adverse

hyperpigmentation,

diabetes

mellitus,

cardiovascular disease, reproductive defects, and cancers of the liver, bladder, skin, lung,
kidney, and prostate, have been associated with arsenic exposure (9-17). The most
common route of exposure is the ingestion of arsenic contaminated drinking water, which
has been documented in Latin America, South Asia, Taiwan, the United States, and Japan
at concentrations as high as 1.5-3.4 mg/L (18-25). These figures exceed the World
Health Organization’s maximum contaminant level of 10 ug/L by ten-fold or more. In
the U.S. alone, an estimated 56 million Americans are exposed to concentrations of
arsenic known to cause cancer (18,19,23-25).
Arsenic was first suggested to act as a human carcinogen by Hutchinson in the
year 1887 when he noticed an abnormal number of skin cancers occurring in patients who
were being treated with arsenicals (19). Since then, epidemiological studies have shown
that arsenic exposure is associated with cancers of the skin, lung, liver, bladder, and
prostate (9-12).

In 1980, Rossman et al showed that inorganic arsenic was poorly

mutagenic and genotoxic in both E. coli and CHO cells (26). Although arsenic induces
DNA adduct formation, DNA-protein crosslinks, and ROS formation in vitro, attempts to
examine the in vivo carcinogenic effects of arsenic in rodent models have largely failed in
the absence of another carcinogenic agent (27-29).
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Because of arsenic’s poor mutagenicity, the current theory is that its carcinogenic
effects are mediated by epigenetic mechanisms. This hypothesis is supported by the
studies of Chen et al, in which overexpression of the oncogene c-myc and DNA
hypomethylation of the promoter region of the estrogen receptor alpha gene have been
observed in liver tumors of adult rats exposed to arsenic in utero (30,31). Additional
supporting evidence includes the identification of the Erk MAPK as an essential
component of the signal transduction pathways responsible for arsenic-induced
transformation of JB6 murine fibroblast cells in vitro (32). Other studies have suggested
that arsenic may prevent signaling events leading to cellular differentiation. For example,
inorganic arsenic has also been shown to suppress involucrin expression, a marker of
keratinocyte differentiation (33).
Although the previously described studies strongly suggest that gene expression
and protein signaling events activated and suppressed during arsenic exposure play a
central role in arsenic-induced tumorigenesis in vitro, knowledge of the signaling
mechanisms responsible for transformation in a human model system remain virtually
non-existent. Several colleagues have examined the transcriptional profiles of cell lines
and tissues that have been exposed to arsenic. Examples include Liu’s group (34), who
showed that hepatocellular carcinoma induced by arsenic exposure in utero upregulated
the expression of 56 genes and downregulated the expression of 26 genes when compared
to non-tumor liver samples from CH3 mice. Moreover, gene expression changes in a
BEAS-2B cell line differed between low (5 μM) and high (50 μM) doses of arsenic. In
the high dose samples, general stress response genes were induced, whereas more subtle
changes were observed at a lower dose of arsenic (35).

3

To date, only three groups have examined the effects of arsenic in mammalian
models on a proteomic scale (36-38).

Yet, both Lau’s and He’s groups used a rat lung

epithelial cell line in which arsenic-induced transformation was not observed (37). In
addition, He’s group used the known carcinogen benzo-a-pyrene in conjunction with
arsenic treatment (36). Furthermore, Wang’s group chose to study only the nuclear matrix
fraction of the K562 chronic myelogenous leukemic cell line in which arsenic is known
to induce apoptosis, not transformation (38).

In spite of the valuable information

provided by these studies, an understanding of the signaling pathways responsible for
arsenic-induced carcinogenesis is still in its infancy.

GADD45α
One epigenetic mechanism by which arsenic may induce carcinogenesis is
through the dysregulation of the cell cycle. Previous research from our laboratory has
suggested that arsenic can increase the number of BEAS-2B cells found in the G2/M
phase fraction in a dose-dependent manner (39). The GADD45α protein is a major
player in the G2/M phase checkpoint, and a transcriptional profile analysis of the BEAS2B cells showed that the gadd45a gene is upregulated in response to both low and high
dose exposure to arsenic (35).

We therefore hypothesized that GADD45α may be

involved in arsenic’s ability to induce G2/M phase arrest.
The involvement of GADD45α in the G2/M phase checkpoint is thought to occur
through its interaction with the cyclin dependent kinase cdc2 (also known as cdk1).
GADD45α is thought to bind to cdc2 and sequester it in the cytoplasm preventing cdc2
from associating with its cyclin counterpart, cyclin B1 (40).

Recombinant GADD45α
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(rGADD45α)

protein

expression

has

been

shown

to

prevent

cdc2

from

immunoprecipitating with cyclin B1, thus specifically inhibiting cyclin B1/cdc2dependent phosphorylation of its target protein histone H1 in vitro (40).
Additional functions of GADD45α have also been proposed.

For example,

Smith et al have shown that GADD45α and the proliferating cell nuclear antigen (PCNA)
coimmunoprecipitate in ML-1 human myeloid leukemia cells containing a functional p53
gene upon exposure to ionizing radiation (IR) (41). PCNA is a sliding clamp ring protein
that functions in DNA synthesis and recruits DNA repair proteins to the site of DNA
damage (42).

Furthermore, rGADD45α addition has also been shown to stimulate

nucleotide excision repair (NER) in both ML-1 and RKO cells (41). Taken together,
these results suggest that PCNA may recruit GADD45α to the site of DNA damage
during cellular proliferation, implying a role for GADD45α as a link between the DNA
damage sensing machinery and DNA damage repair.
GADD45α has also been shown to play a role in G1/S phase arrest. Exposure of
mouse embryo fibroblasts to IR can induce a p53-dependent G1/S phase arrest (43).
GADD45α mRNA was increased after IR in the wild-type p53 ML-1, RKO, WI38, 344,
U2-OS cell lines, but not in p53-deficient cell lines (43). Furthermore, p53 deficiency
prevented GADD45α mRNA induction and led to a loss of G1 arrest after IR (43). An
alternative mechanism of GADD45α action at the G1/S phase checkpoint suggests that it
can prevent DNA synthesis from occurring, since a Balb/c-3T3 fibroblast GADD45αIPTG-inducible cell line can inhibit entry into S phase when IPTG is present (44).
Another function of the GADD45α protein is to allow for topoisomerase I
relaxing and cleavage activity (45). Addition of GADD45α and core histones can relax

5

supercoiled DNA (45). GADD45α can directly bind histones H1, H2A, H2B, H3, and
H4, and subsequently interfere with their ability to interact with DNA (45). Furthermore,
DNAse I sensitivity increased when GADD45α was added in the presence of
hyperacetylated nucleosomes (45). GADD45α can bind only hyperacetylated
nucleosomes

(not

underacetylated)

and

can

also

mononucleosomes and free DNA damaged by UV (45).

bind

UV-damaged

DNA

The region of the protein

responsible for these interactions is contained in amino acids 71-124 (45). Interestingly,
this is the same region of the GADD45α protein responsible for preventing cdc2/cyclin
B1 kinase activity and phosphorylation of histone H1.

Regulation of GADD45α
gadd45a is an inducible gene that was isolated as a novel mRNA increased after
DNA damage (46). It is induced by many different types of cellular stress including
methylmethane sulfonate (MMS) treatment, medium starvation, ionizing radiation (IR),
ultraviolet radiation (UV), and sodium arsenite (47). Depending on which type of
stressor is present in the system, the mechanisms of gadd45a induction differ. The most
studied mechanism is the p53-dependent mechanism; however, a p53-independent
mechanism also exists.
In some cases, the first step required for the transcription of inducible genes is the
remodeling of nucleosomes. This allows the transcription factor to bind to the inducible
gene and increase gene expression. In other cases, the nucleosomes have already been
arranged around the transcription factor binding sites, allowing for quick binding of the
selected transcription factor at any time. The gadd45a gene is thought to be one of these
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so-called preset genes, in which the nucleosomes are arranged such that the promoter
region and the 3rd intron are poised for easy access to transcription factors, since these
regions are hypersensitive to DNase cleavage (48). Therefore, most studies of gadd45a
transcriptional regulation have focused on the promoter and 3rd intron regions.

p53
The p53-dependent mechanism of gadd45a induction is usually seen in response
to IR exposure. Graunke et al, have shown that IR treatment causes a 15-fold induction
of gadd45a mRNA as measured by northern blotting in the absence of de novo protein
synthesis (48). In addition, Zhan et al have shown that the p53-dependent induction of
gadd45a occurs via p53 binding to its consensus sequence in the 3rd intron of the
gadd45a gene and subsequently interacting with the WT1 transcription factor (49).
However, this response seems to be strictly employed only with exposure to IR.

Oct-1
Oct-1 is a ubiquitously expressed cis-regulatory transcription factor of the POU
(pit-oct-unc) family. It has been shown to regulate the transcription of many genes,
including histone H2B, the small nuclear RNA gene, immunoglobulin genes in B cells,
the von Willebrand factor, TIF2, GnRH, and the vascular cell adhesion molecule
(VCAM) gene (50,51). The Oct-1 transcription factor has also been shown to bind the
promoter region of the gadd45a gene between -101 to -82 bp relative to the
transcriptional start site (TSS) in a p53-independent manner following MMS treatment
and UV irradiation (50-53).
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Takahashi and colleagues have suggested that a cofactor is needed in order for
Oct-1 to induce gadd45a transcription in response to UV treatment (50). Jin et al have
suggested that this cofactor may be the ubiquitous NF-YA transcription factor which
binds to a CAAT-box motif located in the same region of the gadd45a promoter as the
Oct-1 binding motif. Both Jin and Zhao found that Oct-1 is induced in response to MMS
treatment, which contradicts Takahashi’s results suggesting that Oct-1 abundance was not
increased in response to UV stimulus (50-52). Jin also suggests that Oct-1 protein
induction is mediated through a post-transcriptional mechanism (PTM), whereas
Takahashi claims that the Oct-1 protein is not modified (50,51). These differences could
be due to differences in the cell lines examined or the stimulus used for the induction of
gadd45a. Both Takahashi’s and Jin’s work is supported by that of Graunke et al, in
which LMPCR was used to identify potential protein binding interactions, one of which
was the Oct-1 transcription factor (48).

ZBRK1
ZBRK1 is a zinc finger protein that is thought to repress gadd45a transcription
by binding to the 3rd intron in a BRCA1-dependent manner (54). BRCA1 itself cannot
bind directly to a regulatory DNA sequence; it must associate with a transcription factor
that is capable of binding to a specific DNA sequence. There may be additional ZBRK1
binding sites in the gadd45a promoter region (54). Many other genes besides gadd45a
contain putative ZBRK1 binding sequences, including GADD153, Ki-67, Bax, p21,
EGR1, amphiregulin, prothymosin, TIMP-1, TIMP-2, and Topo IIa, suggesting that
ZBRK1 may be involved in the cellular response to DNA damage (55). Yun et al have
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recently shown that upon UV and MMS exposure, ZBRK1 is rapidly degraded (within 30
minutes) by the ubiquitin proteasome pathway, which subsequently results in an increase
in GADD45α protein expression (54). One possibility is that stress activation of BRCA1
could promote the degradation of ZBRK1 through its E3 ubiquitin ligase activity,
relieving gadd45a gene repression.

c-Myc
c-Myc is a well-known oncogene that increases its expression in response to
mitogens. Its de-regulation prevents cells from exiting the cell cycle and from
responding to growth-arrest signals. c-Myc has been shown to regulate many cell cycle
control genes including Cdc25a, eIF-4E, C/EBPα, cyclin D1, GADD153, and most
recently GADD45α (56). Marhin et al, report that c-Myc activation represses gadd45a
transcription and that this process requires de novo protein synthesis (56). Interestingly,
amino acids 106-143 of c-Myc are required for suppression of gadd45a transcription, the
same region required for cell cycle progression and c-Myc-induced cellular
transformation (56). Despite the absence of a canonical c-Myc binding site in the
gadd45a gene, c-Myc represses its transcription possibly by inhibiting CAAT-binding
transcription factors such as the CTF/NF1 or C/EBP family of transcription factors (52,
56). Graunke’s LMPCR results in ML-1 cells support Marhin’s results, suggesting that
C/EBP binds to the gadd45a promoter region (48).
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NF-κB
UV treatment has also been shown to activate NF-κB, a known inhibitor of JNK
expression. NF-κB is thought to cause an inflammatory response and has been shown to
be overexpressed in many cancer cell systems. Zerbini et al have recently reported that
NF-κB can repress gadd45a transcription in an indirect manner by activating c-Myc (57).
After inhibiting NF-κB activation, an increase of approximately 3-fold in GADD45α and
γ mRNA was observed (57). The inhibition of NF-κB is thought to prevent cell
proliferation and increase apoptosis, both of which have been suggested to be functional
roles for the GADD45 family of proteins.

FOXO3a
FOXO3a is a member of the forkhead transcription factor family, and its sequence
is similar to that of the DAF-16 gene in C. elegans, which is required for SOD and
catalase transcriptional upregulation. DAF-16 has been shown to be involved in stress
resistance and an increased life span, whereas FOXO3a overexpression has been shown
to result in G1 arrest (58). FOXO3a is a downstream target of the PI3K and PKB/Akt
pathway, which promotes cell survival. PKB/Akt phosphorylates and inhibits FOXO
transcription factors, sequestering the transcription factor in the cytoplasm. Tran et al,
have shown that inducible expression of an Estrogen Receptor-FOXO3a fusion protein
with 4-hydroxytamoxifin can induce gadd45a promoter luciferase activity in a Rat-1 cell
line (58). Tran and colleagues identified the positions of the forkhead response elements
(FHREs) in the gadd45a promoter region at -505, -377, and -803, relative to the TSS.
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In cells passing through the G2 phase, FOXO3a was localized to the nucleus. In
addition, constitutive expression of FOXO3a led to a G2/M phase delay as did treatment
with a PI3K inhibitor, LY294002. Furthermore, overexpression of FOXO3a managed to
repair a UV damaged CMV-luciferase construct in RKO and MEF cells. Tran et al also
showed that FOXO3a could bind directly to the FHRE2 and FHRE3 elements in the
gadd45a promoter region (58). All of the FOXO3a effects on G2 arrest and the UV
damaged CMV luciferase construct were diminished in a GADD45α -/- fibroblast cell
line, suggesting that the effects of GADD45α are at least in part mediated through a
transcriptional increase of GADD45α protein by FOXO3a (58).

Post-Transcriptional Regulation
In addition to transcriptional upregulation, GADD45α has also been shown to be
post-transcriptionally regulated. Rishi et al observed a four-fold increase in the amount
of GADD45α mRNA stability in a human breast carcinoma cell line after treatment with
the synthetic retinoid CD437 which has been shown to cause G0/G1 arrest and apoptosis
(59). Rishi’s group further established that GADD45α mRNA stability is dependent upon
45 base pairs of the 5’ untranslated region (UTR) of the GADD45α mRNA (59). Rishi’s
report is the only published report of post-transcriptional regulation of the GADD45α
protein.

Working Hypothesis
Because GADD45α is a stress-inducible protein that is responsive to a multitude
of DNA damaging agents each with their own mechanism of action, it is reasonable to
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suggest that its induction may be related to the production of ROS. UV-irradiation, IR,
and sodium arsenite have all been shown to produce ROS in cellular systems and also
induce GADD45α expression (60). We have therefore hypothesized that ROS can act as
second messengers to induce the GADD45α protein and possibly mediate the effects of
ROS on the cell cycle, apoptosis, and DNA damage repair. The experimental research
presented in this manuscript suggests that arsenite can transcriptionally induce
GADD45α expression via the formation of H2O2 through a Fenton-like reaction
mechanism.
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SECTION II

Environmental Health Research in the Post-Genome Era: New
Fields, New Challenges, and New Opportunities
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ABSTRACT

The human genome sequence provides researchers with a genetic framework to
eventually understand the relationship between gene-environment interactions. This
wealth of information has led to the birth of several related areas of research including
proteomics, functional genomics, pharmacogenomics, and toxicogenomics. Developing
techniques such as DNA/protein microarrays, siRNA applications, 2-D gel
electorphoresis and mass spectrometry in conjunction with advanced analytical software
and the availability of internet databases offers a powerful set of tools to investigate an
individual’s response to specific stimuli. Here, we summarize these emerging scientific
fields and techniques focusing specifically on their applications to the complexities of
gene-environment interactions and their potential role in environmental biosecurity.
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Introduction
Environmental exposure, genetic susceptibility, and age undergo a set of complex
interactions to induce human disease (Rall and Groopman, 1994; National Institute for
Envrionmental Health Sciences (NIEHS): Intro to NIEHS, 2002). The prevention and
treatment of human disease relies on the ability to understand the exact cause and effect
relationship among these factors and to identify which events are involved in the onset
and progression of disease. The recently completed draft sequence of the human genome
could create seemingly endless opportunities for the delineation of gene-environment
interactions. By determining the relationship between environmental exposure and
genetic susceptibility, the environmental health research community has the ability to
unlock these mysteries.
Since the inception of the Human Genome Project in 1990 (Fink, 1990), new
avenues of research such as proteomics, functional genomics, and toxicogenomics have
rapidly emerged. In February 2001, two separate drafts of the human genome sequence
were published (Venter et al, 2001; International Human Genome Sequencing
Consortium (IHGSC), 2001). In April of 2003, the IHGSC finally announced the
completion of the human genome sequence (Pennisi, 2003; National Human Genome
Research Institute, 2003). New techniques including DNA microarrays, small-interfering
RNA (siRNA), and protein microarrays have already yielded promising results towards
improving health and treating human disease (Heller et al, 1997; Novina et al, 2002;
Belov et al, 2001). By integrating information gathered from the human genome
sequence, epidemiological surveys, and gene-association/susceptibility studies, it may be
possible to determine how genes and environmental stressors are interrelated. These
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studies could lead to the generation of novel strategies for treating diseases with
underlying genetic components. Here, we discuss advances in the new fields and
techniques that have emerged with the promise of a complete human genome sequence
and their applications to gene-environment interaction studies.

Environmental Exposure and Genetic Susceptibility
Humans are continually exposed to hazardous agents in the environment through
air, water, soil, diet, and the workplace (Churg et al, 2003; Tsai et al, 1999; Malaka et al,
1990; Gambelunghe et al, 2003). Previously, there have been many studies focusing on
the acute effects of high-dose exposure to environmental agents. However, much less
data is available concerning the effects of low-dose chronic exposure to many
environmental agents. Chronic exposure to an environmental toxin, even at a low dose,
can be just as harmful to an organism as an acute exposure. For example, toxic agents
such as cadmium have been shown to accumulate in tissues over time and lead to
multiple adverse effects in exposed individuals (Hunder et al, 2001; Staessen et al, 1999).
However, not all individuals who are exposed to an environmental agent will manifest
disease, suggesting that many of the effects resulting from a low-dose chronic exposure
to an agent may have a complex genetic and/or non-genetic basis. Further complications
of exposure assessment include variations in the route of exposure, concentrations of the
toxic substance, and the number and length of exposures, rendering each individual’s
exposure pattern unique.
It has long been thought that the genetic makeup of each individual plays a key
role in the cellular response to a toxic agent (International SNP Map Working Group,
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2001). There are several types of genetic variations that have been observed in humans,
including the loss of one or both alleles for a specific gene, alternative splicing variants,
and the presence of single nucleotide polymorphisms (SNPs), which are the most
common type of genetic variation. An example of the effect of genetic variation on a
cellular process is illustrated by the different expression levels of several cellular
antioxidant enzymes in Type 1 Diabetes patients (Hodgkinson et al, 2003).

When cells

and tissues are exposed to a toxic agent such as Cr(VI), the antioxidant enzymes are
triggered as a defense system to repair the cellular damage. If, however, a large amount
of cellular damage is induced by the Cr(VI) exposure, then the balance between the
antioxidant defense mechanisms and the oxidants may be upset. The oxidant-induced
damage may be permanent and lead to apoptotic or necrotic cell death (Ye et al, 1999).
Environmental exposure to agents such as chromium, arsenic, and nickel has been shown
to affect several cellular signaling pathways, suggesting that an individual’s genetic
variation in any gene involved in these pathways could potentially affect susceptibility
(Barchowsky and O’Hara, 2003; O’Hara et al, 2003; reviewed in Chen and Shi, 2001).
As a result, a Type I Diabetes patient that is subsequently exposed to an environmental
insult may have a less effective antioxidant defense system than that of a non-diabetic.
There are several ways a toxic agent can elicit a cellular response. For example,
an inappropriate activation or modification of proteins involved in the cell survival/DNA
repair/apoptotic signaling pathways can lead to increased non-specific tyrosine
phosphorylation (Qian et al, 2001). Toxic agents, such as nickel, arsenic, and cadmium
may also inhibit enzymes responsible for protection from carcinogenic agents (Poirier
and Vlasova, 2002). In addition, toxic agents have also been shown to induce mutations,
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such as the mutation of two domains of the insulin-like growth factor 1 receptor (IGF-1R)
involved in a radio-resistant signaling pathway in mouse embryo fibroblasts (Yu et al,
2003). The previous examples suggest that exposure to toxic agents occurs through many
different mechanisms, each of which must be fully investigated in order to prevent and/or
treat the diseases that result. In addition to the myriad of disease mechanisms that may
exist, genetic influences may also play an important role in these mechanisms. Until
recently, however, the tools and technology necessary to investigate the genetic influence
on diseases of environmental exposure were inadequate. The sequencing of the human
genome has provided us with a blueprint to begin studying the gene-environment
interactions and the cellular signaling processes that lead to complex, geneticallyassociated diseases such as Parkinson’s, Alzheimer’s, and cancer.

Single Nucleotide Polymorphisms (SNPs)
One of the most promising immediate benefits of sequencing the human genome
is the current effort to catalog all of the human SNPs. Persons displaying a SNP - a
single nucleotide substitution, deletion, or addition in any given gene or regulatory region
- are potentially at risk for responding to their environment in a different manner from
those who contain the consensus “normal” allele of the given gene. Techniques to
determine the effects of these polymorphisms are playing an important role in
pharmaceutical research and in the investigation of disease onset. An example is the
cytochrome P450 2D6 (CYP2D6) gene encoding debrisoquine 4-hydroxylase, which is
involved in the metabolism of many drugs and some neurotoxins. The poor metabolizer
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polymorphisms of this gene have been implicated in the pathogenesis of neurotoxininduced Parkinson’s disease (Payami et al, 2001).
SNPs are the most common type of genetic variation – purportedly occurring at a
rate of 1 per 1300 bases with a grand total of 1.42 million located in the human genome and are thought to be the most likely candidates for complex polygenic susceptibility to
disease (Venter et al, 2001; IHGSC, 2001; International SNP Map Working Group, 2001;
Wolfsburg et al, 2001; Altshuler et al, 2000). Several disease genes have already been
discovered; the IT15 gene responsible for Huntington’s disease, the ADAMTS13 gene
involved in thrombotic thrombocytopenic purpura, the lamin A gene (LMNA) which is
thought to be the underlying cause of Hutchinson-Gilford progeria syndrome, and the
CLN2 gene product associated with late-infantile neuronal ceroid lipofuscinosis (LINCL)
(Huntington’s Disease Collaborative Research Group, 1993; Levy et al, 2001; Eriksson et
al, 2003; Sleat et al, 1997). However, most of these genes are linked to rare conditions in
which the mutation of only one gene seems to cause the disease (International SNP Map
Working Group, 2001). More complex genetic diseases in which mutations must be
present in multiple genes are much more difficult to identify. The identification of such
genes will require the characterization of all of the existing SNPs in combination with
association studies of individuals at risk (Lander, 1996; Collins et al, 1997).
It has already been established that certain SNPs play a pivotal role in the
manifestation of disease, either by increasing the risk for disease, by preventing disease
progression, or by affecting transcriptional regulation. For example, an ApoE4 SNP has
been shown to increase senile plaque density, rendering this SNP a risk factor for
Alzheimer’s disease (Hofmann, 2001). On the other hand, the deletion of base pair 32 of
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the CCR5 co-receptor gene prevents HIV uptake by T4 lymphocytes, rendering any
individual possessing this SNP resistant to HIV infection (Lander, 1996; Hofmann,
2001). Finally, cases in which a SNP removes, adds, or alters a transcription factor
binding site which lead to a disease phenotype have been documented (Ponomarenko et
al, 2002; Ponomarenko et al, 2003). To date, most of the research of genetic disease has
focused on mutations in single genes, mainly because complex genetic interactions are
difficult to study (Collins et al, 1997). However, by performing gene-association studies
utilizing an SNP catalog, researchers can study the complex interactions between
multiple genes when exposed to an environmental toxicant (International SNP Map
Working Group, 2001; Collins et al, 1997).
Many SNP databases are available for public use, including the dbSNP and the
SNP Consortium database, both of which currently contain only human SNP data
(International SNP Map Working Group, 2001; Smigelski et al, 2000; Wheeler et al,
2003). Other more specialized types of SNP databases have also been created, including
the rSNP_Guide, which allows users to search for novel human transcription factor
binding sites created, deleted, or altered by SNPs (Ponomarenko et al, 2002;
Ponomarenko et al, 2003). By utilizing the vast array of information found in such
databases, one can begin to explore the probable cause and effect relationship between
SNPs and specific gene-environment interactions leading to disease susceptibility.
However, many questions remain to be answered concerning the role of genetic
polymorphisms in disease progression, including the following: How do these SNPs
facilitate disease? Is it a result of the polymorphic gene’s inability to produce its
functional protein product? Does the polymorphism destroy some binding sequence
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required for a particular signaling pathway? Or does the polymorphism interfere with or
negate the immune response to that agent? Can prior exposure create a sensitization
effect, i.e. does it influence genetic susceptibility to a second exposure by worsening the
effects of subsequent exposure over time? Can genetic susceptibility change or
breakdown over time as a person ages? These questions will have to be answered for all
of the SNPs involved in a disease in order to fully understand the gene-environment
relationship between exposure and disease.

Environmental Genome Project (EGP)
In light of all the questions surrounding genetic susceptibility and environmental
exposure, the NIEHS founded the Environmental Genome Project (EGP) in 1997 (EGP –
History, 2003). The purpose of the EGP is to increase the available knowledge and
information about the effects of environmental exposure and the role genetic variation
plays in human susceptibility to disease. Specifically, the EGP focuses on re-sequencing
parts of the human genome, looking for polymorphisms that may be involved in genetic
susceptibility to a range of diseases (EGP – Overview, 2003). The EGP has identified a
group of environmentally responsive genes and categorized them into the following eight
groups: cell cycle, DNA repair, cell division, cell signaling, cell structure, gene
expression, apoptosis, and metabolism (EGP – Environmentally Responsive Genes,
2003). The goal is to compare and cross-screen the re-sequenced regions of the human
genome, analyzing each identified polymorphism and determining whether or not it is
functionally significant. Discovering the identity of the functionally significant
polymorphisms is crucial to linking genetic susceptibility to specific diseases. Together
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with thorough epidemiological surveys, genetic polymorphisms can help determine
which environmental and genetic factors may interact to produce disease.
Although studying gene-environment interactions via SNP comparisons is a
promising avenue of exploration, some problems may complicate these studies. For
instance, disease is not always caused by a single trait; it sometimes involves several
traits, and the algorithms available may not be able to deduce a correlation between broad
sets of SNPs and environmental factors. Therefore, establishing clear-cut relationships
between particular genes and their environmental inducers may not always be possible.
These issues will have to be addressed in order to fully understand the mechanisms by
which genes and their corresponding SNPs are influenced by their environment.

Bioinformatics and the –omics explosion
As the human genome project neared its completion, the new field of functional
genomics began to surface. Functional genomics encompasses the identification and
analysis of the entire gene and protein content of an organism (Fields et al, 1999;
Strausberg and Austin, 1999). Since then, all of the questions originally proposed under
the term functional genomics seem to have taken on their own personalities, and have
each become their own –omics field. The fields of bioinformatics, proteomics, and
structural genomics, are a few of the fields that have evolved in this manner.
Developments in these fields will likely facilitate the understanding of the underlying
mechanisms of gene-environment interactions and their relationship to human disease.
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•

Bioinformatics
The field of bioinformatics collects, analyzes, and disseminates the raw sequence

data of a genome (D Trends, 2003). Researchers are currently trying to create better
analytical software and more powerful algorithms to determine which specific sequences
correspond to genes or their regulatory regions, and which sections do not play a role in
the production of proteins or their regulation. These powerful computer programs will
allow bioinformaticians to complete an annotated version of the human genome revealing
the number of genes it contains. They will also help to predict the regulatory regions,
functionally significant regions, and transcription factor binding sites in unknown genes.

•

Proteomics
The term “proteome”, coined by Marc Wilkins, refers to the total set of proteins

encoded by a particular genome (Wilkins et al, 1996). Even before the determination of
the complete sequence of the genome, proteomics scientists had already begun to tackle
the proteome via techniques involving the coupling of 2D polyacrylamide gel
electrophoresis and chemical composition analysis by mass spectrometry (Wilkins et al,
1996). By determining the complete contents of the proteome, proteomics scientists hope
to discover new protein biomarkers for diseases by examining differences in protein
expression levels, post-translational modifications, and the differential expression of
proteins between disease and non-disease states. With the development of highthroughput protein analysis methods, such as protein arrays, the identification and
cataloging processes can be streamlined. A list of several databases containing
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information about protein sequences, 2D gel information, and 3D protein structures is
available at the Expert Protein Analysis System (ExPASy) website (Fig. 1) (James,
1997).

•

Structural Genomics
With the increasing amount of genomic and proteomic data available, structural

genomics has found its own niche. The aim of structural genomics is to characterize the
structures of representative proteins for each protein family. Several methods,
particularly x-ray crystallography and nuclear magnetic resonance (NMR), are used to
provide a set of reference structures that will serve to help determine the structures of
similar families of proteins. The Protein Structure Initiative (PSI) sponsored by the
National Institute of General Medical Sciences has attempted to create a database of the
structures of all proteins determined to date (See Fig. 1 - PSI website). Structural
genomics scientists can then use the information gained through DNA coding sequences
to predict primary protein sequence, which can be further analyzed and compared to
known three dimensional structures by computer homology modeling techniques (Yao,
2002).
Computer homology modeling methods play a major role in predicting the tertiary
structure of proteins by comparing the sequence of a protein of unknown structure to the
sequences of structures that have already been determined via the use of computer
databases. Examples of such databases include Entrez’s Molecular Modeling Database
and the ModBase database (Wheeler et al, 2003; Yao 2002; Chen et al, 2003). These
databases have been employed to determine the physical structure of many proteins and
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allow public access to the structure and functional domain data generated for known
proteins. The identification of a protein’s tertiary structure leading to the recognition of
common interaction domains, can offer critical information concerning that protein’s
function. Recognition of these common binding domains may help to predict novel
interactions with other proteins or cellular constituents. Thus, these results could be
extrapolated from database resources and used to increase the rate at which candidate
proteins can be examined in biological systems - all based solely on their sequence
identity and homology to similar proteins.
In addition to comparing the primary sequence of two proteins, the structural
databases can be used to compare the tertiary structures of two proteins. Comparing the
tertiary structure of proteins may be helpful when comparing two proteins that are
functionally equivalent, but evolutionarily diverse (Holm and Sander, 1996). With new
technologies developing in the field of structural genomics, the goal of structurally
characterizing the entire proteome may soon be attained, allowing researchers to
investigate gene-environment interactions at the proteomic level.

Using Bioinformatics to Fuel New Directions in Environmental Health Research
Bioinformatics, proteomics, and structural genomics have produced a large
amount of sequence and structural data very quickly. The need for interpretation of this
massive quantity of information has led to the development of many new specific
disciplines including, but by no means limited to, metabolomics, pharmacogenomics, and
toxicogenomics. In addition to these specialized fields, more comprehensive fields such
as comparative genomics and systems biology have evolved, both of which attempt to
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make more global inferences from a large scale interpretation of all genomes sequenced
to date (Yao, 2002).

•

Metabolomics
The field of metabolomics attempts to decipher the different interactions between

signaling pathways by characterizing differences in the metabolome – all of the
metabolites present at any given time in a biological sample (Muller and Kersten, 2003).
Metabolomic profiles have been used to determine genotypic differences between
Arabidopsis thaliana plants through the use of neural networks and to study metabolic
fluxes in tumor tissue (Taylor et al, 2002; Griffiths and Stubbs, 2003). Raamsdonk et al,
has recently shown that genes exhibiting no overt phenotype can be studied using a
method called functional analysis by co-responses in yeast (FANCY) that detects changes
in metabolite concentration of a cell rather than an overall growth effect (Raamsdonk et
al, 2001). Metabolomics studies have also been shown to be useful in the discovery of
new toxicity biomarkers, such as the study by Lindon et al, in which 1H-NMR
spectroscopy was used to identify novel biomarkers in rat bodily fluids (Lindon et al,
2002). EcoCyc, a database that describes the metabolic and signal transduction pathways
of Escherichia coli, and MetaCyc, which contains metabolic and signal transduction data
for many other organisms have recently been developed (Karp et al, 2000). Since heart
disease has been linked to aberrant cholesterol metabolism, advances in the field of
metabolomics could provide major contributions to environmental health researchers
investigating the mechanisms responsible for heart disease.
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•

Pharmacogenomics

Pharmacogenomics is a field which aims to identify and characterize the various
polymorphisms, including SNPs, present in different individuals that may affect a
patient’s response to a drug (Altman and Klein, 2002). Examples of an important class of
highly polymorphic genes include the cytochrome P450 (CYP450) enzymes, many of
which are responsible for the metabolism of an array of currently available
pharmaceuticals. Currently, new technical avenues are being explored to determine a
patient’s genetic compatibility with a drug before a treatment is prescribed. This type of
precautionary testing would protect a patient in the event that he or she possessed a
polymorphism affecting the metabolism of that drug. Although it has been suggested that
less than 1% of SNPs affect the predicted protein coding regions in the human genome
(Venter et al, 2001), the SNPs that do affect the coding regions can nonetheless have a
crucial effect on the treatment of patients. For example, potentially toxic thiopurine
drugs, such as 6-mercaptopurine which is metabolized by thiopurine methyltransferase
(TPMT), are administered to children with acute lymphoblastic leukemia (Weinshilboum,
2001). Since thiopurines have a very narrow therapeutic index and the levels of TPMT
are controlled by a common polymorphism, it is necessary to individualize thiopurine
therapy to prevent fatal thiopurine toxicity (Weinshilboum, 2001). Other examples have
also begun to pave the way for the individualization of medical treatment. The new
Genentech drug Herceptin is being used to treat only the 20-30% of breast cancer patients
that overexpress the her-2/neu receptor (Service, 2003). Advances in the field of
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pharmacogenomics could revolutionize the way a doctor prescribes drugs for his or her
patients.

•

Toxicogenomics

Toxicogenomics is dedicated to the elucidation of the role genes play in response to
environmental toxicants and stressors (Hamadeh et al, 2002). NIEHS has recently
developed the Toxicogenomics Research Consortium (TRC) in conjunction with the
National Center for Toxicogenomics Microarray Group (NMG) and has charged them
with the specific tasks of: identifying sites of genetic variability throughout the human
genome, developing standards for the current microarray technology being used to assess
biological responses to environmental stressors/toxicants, and applying this expression
technology in a manner that helps to elucidate the mechanisms of toxicity produced in
response to environmental exposure (Medlin, 2002; National Center for Toxicogenomics
– TRC, 2003). The TRC’s overall goal is to study the relationship between
environmental exposure and disease, and to show how these gene-environment
interactions affect human health. It may be useful to try to develop genome and
proteome “fingerprints” of the different toxicants using array technology, in order to
thoroughly investigate the mechanism of action of these toxins. The Comparative
Toxicogenomics Database (CTD) has been launched in order to provide an annotated
guide to toxicologically significant genes (Mattingly et al, 2003).
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•

Comparative genomics

Comparative genomics encompasses the effort to compare all known complete
genomic sequences to that of the human genome. Complete genomes have now been
sequenced for many of the most popular model organisms currently used in research,
including the A. thaliana plant (Arabidopsis Genome Initiative, 2000), the worm
Caenorhabditis elegans (C. elegans Sequencing Consortium, 1998), the fruit fly
Drosophila melanogaster (Adams et al, 2000), the yeasts Saccharomyces cerevisiae
(Goffeau et al, 1996) and Schizosaccharomyces pombe (Maier et al, 1992), and the
laboratory mouse Mus musculus (Mouse Genome Sequencing Consortium (MGSC),
2002). The comparative analysis of all of the sequenced genomes allows the
determination of which human genes have homologous genes in different model
organisms. This allows researchers to make more informed decisions about which model
organism to use for specific studies. If a particular drug is known to exert toxic effects in
a mouse due to a murine-specific gene, then another model organism could be chosen
based on a comparative genomic analysis of several suitable organisms. Thus, some
pharmaceutical studies use non-rodent models, such as dogs and primates, in order to
assess the toxicological effects of certain pharmaceuticals that are not suitable for the
mouse model (reviewed in Smith et al, 2001). Comparative genomics can contribute to
environmental health research in much the same way, by offering alternative model
systems and allowing the elucidation of evolutionarily conserved mechanisms in response
to disease. Perhaps similar genetic association patterns may surface between humans and
non-rodent organisms that are affected by similar diseases.
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•

Comparative Genomics: Sequencing of the Mouse Genome

In December 2002, the long-awaited draft sequence of the laboratory mouse genome,
Mus musculus, was finally published (MGSC, 2002). The comparative genomic analyses
of the human and mouse genomes may prove to be a major factor in decoding the
language of the human genome. Already 342 syntenic segments have been found
between both genomes, marked differences in G/C distribution between the two
sequences have been discovered, and upon examination of CpG island content, the
human genome exhibits about twice as many CpG islands as the mouse genome (MGSC,
2002). Differences in the amount of sequence repeats in the mouse and human genomes
is thought to arise from the activity of transposable elements, which appear to be more
active in the mouse than in the human (Venter et al, 2001; IHGSC, 2001; MGSC, 2002).
Since the mouse is the most studied model for human disease, with 99% of its genes
corresponding to a human homolog, the comparison of the mouse and human genome
sequences will have a significant impact on the future directions of model-driven research
(MGSC, 2002). In addition to the identification of homologous gene pairs, the sequence
identities of many orthologous disease-associated genes have been compared with an
overall amino acid identity approximating 90.3% (MGSC, 2002). These data allow for a
more refined extrapolation of mouse experimental data to human disease states.
Currently, there is a Human-Mouse Homology Map sponsored by NCBI that
allows the comparison of mouse and human homologous segments of DNA. Several
websites also offer access to the entire sequence of the mouse genome, including NCBI’s
Genome Resources website, the Ensembl Mouse Genome Server, and the USC Genome
Bioinformatics website (MGSC, 2002; Wheeler et al, 2003). Additional mouse
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informatics databases can be found at the Jackson, Harwell, and RIKEN websites (See
Fig. 1) (MGSC, 2002).
Aside from comparison applications, the mouse genome sequence will contribute
to the generation of new knockout mice. A new transgenic approach by Lois et al. shows
that an entire mouse can be made to express exogenous genes introduced to the organism
via a lentiviral vector system (Lois et al, 2002). This lentiviral vector system could be
combined with the new siRNA technology (discussed later) to produce knockout mice in
a much more efficient and cost effective manner than traditional methods. It may even be
possible to expand the lentiviral technique for use in fully grown mice to knockout
embryonic lethal genes in a tissue-specific manner. Techniques of this caliber would
provide extremely valuable in vivo data on signaling pathways in the mouse that would
otherwise be impossible to study.

•

Systems Biology

In addition to the birth of comparative genomics, the availability of the complete
human and mouse genome sequences has also catalyzed the emergence of systems
biology, which is the attempt to systematically study all of the physiological processes in
a cell or tissue by global measurement of differentially perturbed states. The ultimate
goal of systems biology is the integration of data from these observations into models that
will eventually represent and simulate all processes of life, including the induction of a
diseased state (Ideker et al, 2001; Kitano, 2002). Advances in proteomics could soon
make the systems biology approach possible. Examples of systems biology approaches
include the galactose metabolism system developed by Ideker et al., the PhysioLab®
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technology created by ENTELOS, and the Cardiome Project reviewed by
Bassingthwaighte (Ideker et al, 2001; Bassingthwaighte, 2000; ENTELOS, 2003).

Current Technology – Global Transcriptional Analysis
The increase in new areas of science prompted by the sequencing of the human
genome coincides with a sudden increase in new technology that can help discover links
between genes and causation of disease in response to environmental agents. By looking
at the expression of a large number of genes at the same time, it is possible to check for
global trends of expression specific to disease states. These trends may not be apparent
to a researcher using traditional time-consuming methods of gene expression
measurement, such as a Northern blot, which relies on a priori knowledge of regulation
events. Several methods have been developed to assess transcription on a global level,
including DNA microarrays, serial analysis of gene expression (SAGE), and massively
parallel signature sequencing (MPSS).

•

Global Transcriptional Analysis – DNA microarrays
One of the most powerful techniques is the DNA microarray, a high throughput

screening method that measures the effects of a stimulus on the mRNA expression of the
entire transcriptome in one comprehensive assay (Schena et al, 1995; Fodor et al, 1993).
Microarray technology utilizes a defined set of probes, each of which represents a
specific transcript. Each probe is arrayed on glass slides to form a microscopic highdensity spot. Total RNA is then isolated from treated and/or control samples and
differentially labeled with fluorescent dyes. Next, a mixed population of labeled RNA
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targets is hybridized to the set of probes. Finally, the amount of fluorescence is
measured by image analysis software and the increase/decrease in gene expression is
determined via statistical analysis of fluorescence intensity. Several databases have been
created to store microarray data, making it available to the public. These include but are
not limited to the Stanford Microarray Database and the NCBI Gene Expression Omnibus
database (See Fig. 1).
An attractive advantage to the microarray assay is that the large amounts of
expression information obtained through one assay can save a tremendous amount of
time by eliminating the need for blind usage of Northern blotting, RT-PCR, western
blotting, and enzymatic assays to analyze gene expression. These time-consuming
techniques can now be utilized on a smaller scale, as a subsequent validation method, to
provide connections for the underlying mechanisms of the signaling pathways (Chin and
Kong, 2002). In addition to the standard use of the assay for gene expression, genomic
microarrays could potentially be employed to detect single nucleotide polymorphisms
(SNPs), since the hybridization between mismatches, even of a 1 base pair magnitude,
can be detected upon quantification of the hybridized probe or by enzymatic treatment in
certain systems (Kolchinsky and Mirzabekov, 2002; Hacia and Collins, 1999).
As more human genes are identified and characterized, the development of
microarrays can be tailored to include specific subsets of related genes that might be of
interest to a researcher. One example would be the development of carcinogenesis chips
that contain oligo probes specific for all known genes involved in cancer pathology.
Toxicology laboratories in the United Kingdom have recently developed a set of
toxicology tailored microarrays known as ToxBlot and ToxBlot II, which are specifically
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for use in toxicogenomic assays (Pennie, 2000; Pennie, 2002). Subset specific
microarray databases, such as the Comparative Toxicogenomics Database (CTD) which
contains toxicogenomic microarray data, are also under development (Mattingly et al,
2003; Medlin, 2002). These types of specialty-tailored microarrays could become more
and more important for the initiation of hypothesis-driven research as we extrapolate
information about the individual genes comprising the human genome.
One of the most useful applications of microarrays is the elucidation of uniquely
affected transcripts in response to a stimulus, producing a so-called fingerprint pattern. It
has recently been shown that microarray data can be useful in diagnosing diseased states
in rats by examining the gene expression pattern of white blood cells, producing a
fingerprint expression pattern unique to a specific disease state (Tang et al, 2001).
Previous studies have also shown that different inflammatory diseases such as
rheumatoid arthritis and inflammatory bowel disease exhibit a differential display of gene
expression upon microarray analysis (Heller et al, 1997). Moreover, lesions of multiple
sclerosis subjected to microarray analysis also produced expression profiles different
from that of normal tissue from the same individual (Whitney et al;. 1999). Most
recently, several laboratories have been able to identify a disease state and even predict
the prognosis of an individual based on the patient’s gene expression profile (Perou et al,
2000; Sorlie et al, 2001; Brenton et al, 2001; Gruvberger et al, 2001). These molecular
fingerprints of disease produced by microarrays may be able to revolutionize the way we
diagnose disease states. Diagnostic microarrays could also be used to identify and assess
the severity of environmental exposure even if symptoms have not yet surfaced. With
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more research pending, this type of disease diagnosis may become an increasingly
powerful tool in the individualization of health care treatment.
In addition to the fingerprint approach to microarray diagnostics, microarrays
could also be instrumental for facilitating the identification of biomarkers specific for
many different types of disease processes (Gerhold et al, 2002; Chin and Kong, 2002). It
has been demonstrated that microarrays can detect alterations in gene expression in
pathological states, such as microbial colonization of the gut and the onset of
inflammation (Heller et al, 1997; Hooper and Gordon, 2001). Gel pad microarrays have
even been used for identification of all types of pathogens - viruses, bacteria, prokaryotes
– and the determination of tuberculosis antibiotic resistance, genetic mutations, SNP
markers, and chromosomal rearrangements (Kolchinsky and Mirzabekov, 2002). The
identification of new biomarkers will allow for the expansion of the available cache of
simple diagnostic tests that can be performed in the laboratories at hospitals, instead of
relying on more technically complicated diagnostic methods, rendering faster and more
definitive results.
Microarray technology also has practical uses and applications in the
environmental health research laboratory. Screening patients for a genetic risk factor is
currently feasible only for a small subset of rare diseases that depend on the mutation of a
single gene. With the newly emerging genetic technology, it is possible that the list can
be expanded to include more diseases, particularly those that are influenced by more than
one gene, such as diseases resulting from low-dose, chronic exposure to a hazardous
agent. This could potentially save many lives by identifying the diseases much earlier,
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allowing doctors to prevent and/or pre-treat diseases before symptoms appear and the
disease’s course has already damaged the patient’s body beyond repair (Grody, 2003).
As there is always a down side to every promising technique, there are also plenty
of disadvantages plaguing the microarray. The microarrays currently used in most
laboratories are not extremely sensitive and may exhibit probe hybridization technical
problems (Kolchinsky and Mirzabekov, 2002). The reliability of the assay is
compromised for genes with repetitive sequence elements or nucleic acids that strongly
favor a secondary structure (Hacia and Collins, 1999). Additionally, since mRNA is
transiently expressed, the expression information obtained through microarray analysis is
limited to a “snapshot” of a biological process. Furthermore, early microarray data has
not been continuously subjected to a set of globally accepted standards, and therefore
much of the microarray data already generated and available in the public databases may
be non-comparable or misleading if not examined carefully and analyzed using the
appropriate statistical methods (Nadon and Shoemaker, 2002).
Microarray technology has also been criticized for creating a large number of
false positives and negatives, for difficulty in reproduction of results between assays and
laboratories, and for providing too much information for realistic interpretation. The
Microarray Gene Expression Data (MGED) Society has begun to address some of these
issues, and is currently trying several approaches such as: developing standards that will
help to reduce variability between assays and laboratories which would increase
reproducibility, requiring annotation of microarray data provided in databases – the
minimal information about a microarray experiment (MIAME) standards, and developing
computer software allowing microarray data to be exchanged between laboratories
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(Brazma et al, 2001 ). With these improvements looming in the not-so-distant future,
microarrays should prove to be an extremely useful tool in the quest for understanding
gene-environment interactions.

•

Global Transcriptional Analysis – MPSS and SAGE
Although DNA microarrays are the most common way to examine transcription

on a global scale, MPSS and SAGE offer certain advantages over the DNA microarray.
The SAGE technique relies on a set of gene-specific probes complexed with streptavidin
beads, each containing a specific tag sequence. The probes and tag sequences are cleaved
from the beads by restriction enzymes and combined to form a unique set of markers for
each transcript. The transcripts are subjected to PCR and sequenced to determine their
identity (Velculescu et al, 1995). A SAGEmap database has been developed for the
dissemination of SAGE data (See Fig. 1) (Lash et al, 2000). Another technique, MPSS,
is very similar to SAGE. The designers of MPSS have generated a large set of
microbeads, each containing a unique tag attached to a gene-specific probe. The beads
containing the tag-probe complex are then mixed with RNA, allowing for hybridization
between the RNA and its specific tag-probe complex, and placed into a flow cell where
up to a million transcripts can be sequenced simultaneously (Brenner et al, 2000).
There are a few advantages to using the SAGE or MPSS approaches over
microarrays. One advantage is that SAGE and MPSS are thought to be more sensitive
than microarrays. They can detect very low levels of transcripts in a system, whereas
microarray experiments may tend to omit some of these low level transcripts. Since the
quantitation of MPSS relies on counting the number of beads with a specific tag instead

46

of hybridizations between a probe and target DNA that may or may not be absolute, the
statistical analysis of MPSS is far more robust than that of DNA microarrays (Brenner et
al, 2000). MPSS is also a much faster technique for global transcriptional analysis than
SAGE, since a million transcripts can be sequenced at a time. MPSS also simplifies
many of the steps required for preparing a DNA microarray experiment, thus reducing the
margin of error in an MPSS experiment.

Current Technology - siRNA
siRNA can also be very useful for the elucidation of signaling pathways induced
by different environmental agents, particularly now that the complete human genome
sequence is available. RNA interference (RNAi) is a naturally occurring mechanism in
which the presence of dsRNA can lead to gene silencing through siRNA intermediates.
siRNAs are 21-23 base pair sequences that are created from larger dsRNA molecules by
an enzyme of the RNase III family called Dicer. The siRNA fragments then associate
with a nuclease complex termed the RNA-induced silencing complex (RISC). RISC
unwinds the siRNA fragments and allows the single-stranded fragment to target
complementary RNA inside a cell, which somehow activates the nuclease activity of the
RISC complex (reviewed in Ambion, 2003).
RNAi was first discovered in the worm, and has been a commonly utilized
technique in the invertebrate world (Fire et al, 1998; Zamore, 2001). Until recently,
RNAi was thought to be an application that could only be used in invertebrate studies,
since a double stranded RNA greater than 30 base pairs in length seemed to activate the
PKR kinase anti-viral mechanism and induce apoptosis in mammalian cells (Ambion,
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2003; Zamore, 2001). However, it was recently discovered that the 21-23 nucleotide
siRNA fragments could bypass the apoptotic mechanism and produce a gene-silencing
effect in mammalian cells (Elbashir et al, 2001). Although the precise details of the
mechanism of siRNA-silencing are not entirely known, it is still an extremely useful
laboratory technique. The short siRNA fragments can be synthetically produced by
silencing vectors, and transfected into mammalian cells, resulting in a decrease of a
specific protein from the system (Elbashir et al, 2001). An advantage of siRNA over the
conventional practice of over-expressing dominant-negative mutants in cellular systems,
is that the siRNA removes endogenously expressed mRNA. This method is also much
easier than creating knockout mutations in cell lines, since it requires only the synthesis
of siRNA fragments and a transfection.
Several labs have recently suggested that siRNA technology could have clinical
applications, such as the inhibition of HIV-1 replication, in addition to its research
applications (Jacque et al, 2002; Novina et al, 2002). Capodici et al. have shown that
they can inhibit HIV-1 infection and replication by transfecting primary CD4+ T cells
with HIV-1 specific siRNA (Capodici et al, 2002). In addition, Qin et al. have developed
a lentiviral-mediated delivery system for siRNA complementary to CCR5 mRNA, the
main HIV-1 co-receptor in primary CD4+ T cells (Qin et al, 2003). This application
seems to lead to the prevention of HIV-1 infection, mimicking the natural immunity to
HIV-1 seen in individuals who lack both CCR5 co-receptor genes (Qin et al, 2003; Dean
et al, 1996). Future siRNA research utilizing approaches such as these, could lead to the
use of siRNA and retroviral gene therapy applicable not only to HIV-1 infection, but to
environmentally-induced disease states as well.
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siRNA could become a very powerful tool for the environmental health research
community. Once the sequence of a particular gene that responds to an environmental
toxin is known, siRNA can be easily exploited to reveal the consequences of removing
that protein from a cellular system. Other suggested uses for the siRNA technology that
could benefit environmental health research include the development of siRNA chips.
These chips would consist of an array of unique siRNA probes fixed to a tissue culture
slide. Cells could then be grown on these chips to show a range of siRNA suppression
based on the siRNA vector the cell takes up, allowing for a high-throughput format for
siRNA studies (Zamore, 2001). In addition, a new type of ssRNA, termed microRNA
(miRNA) or small temporal RNA (stRNA), is thought to function in translation
suppression. These ssRNA molecules may be useful for genetic-silencing experiments as
well (Zamore, 2001; Dennis, 2002).

Emerging Technology – Peptide/Protein Microarrays
With the recent push towards high throughput technology, it only seems natural
that peptide arrays would follow the advent of DNA microarrays. The set up of a peptide
microarray is very similar to that of a DNA microarray. In both cases, a set of unique
probes, or capture agents, are attached to a glass slide, or some other form of solid
support system. The main difference between the two assays is the type of capture agent
that is attached to the slide. In the protein microarray, the capture agent can range from
antibodies, epitopes, and small molecules to sets of recombinant proteins (Tyers and
Mann, 2003). On the contrary, cDNA or oligonucleotide probes are used in DNA
microarrays. The different probes in a protein microarray are chosen depending on what
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type of assay the researcher wants to run. Examples of peptide microarray assays include
binding assays, enzymatic activity assays, protein identification assays, and cell adhesion
assays (Reimer et al, 2002; MacBeath, 2002).
One potential application of a protein microarray is the enzymatic kinase assay.
In this assay, a purified 32P-labeled kinase can be applied to an array utilizing peptides as
capture agents. Each protein probe that is phosphorylated by that specific kinase would
then bear the radio-label (MacBeath and Schreiber, 2000). Alternative uses of the protein
microarray include the use of antibody probes, which could detect specific proteins from
a mixed solution of total protein isolated from a test subject (Belov et al, 2001). The
development of yet another peptide microarray assay includes the placement of different
proteins onto the glass slide and washing the slide with a mixture of differentially
fluorescent labeled proteins in order to determine protein binding interactions (MacBeath
and Schreiber, 2000). Assays such as these could advance the discovery of biomarkers
important for the identification of diseased-state phenotypes. These assays may also help
elucidate exciting new protein-protein interactions.
Although peptide microarray technology is still in its infancy, the advantages are
apparent. In particular, the arrays offer a high-throughput advantage over traditional
methods such as yeast-two hybrid screens, fluorescence resonance energy transfer
(FRET), and the traditional biochemical assays coupled to mass spectrometric analysis
(reviewed in Phizicky et al, 2003). Protein microarrays can also help fill in the gaps left
by DNA microarrays, since DNA arrays are indifferent to some forms of genetic
regulation, such as post-translational regulation and protein degradation. The
development of solid protein profiling techniques and applications would allow
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researchers to supplement the information gained through DNA microarray studies. In
addition, a global analysis of the entire proteome could lead to the quick discovery of
protein-protein interactions that may have taken years to notice with a small scale
approach.
Currently, however, it is not yet technically possible to determine the entire
content of a proteome with a protein microarray. Several complicating factors, such as
the existence of unknown differential splice variants and post-translational regulation
events undergone by many proteins, make it difficult to develop capture agents for these
currently unknown proteins. Difficulties also arise during the production of the capture
agents that are needed to specifically interact with only a single protein. Another
disadvantage of protein arrays that measure specific binding to a set of capture agents is
that attachment to the slide must not alter the structure or function of the capture agents
(MacBeath, 2002). Yet another issue relates to the difficulty of synthesizing the proteins
on the glass slide, possibly creating a bias as to which proteins get studied, e.g. the easiest
ones to synthesize on the slide. Other concerns have been voiced about the difficulties of
miniaturizing the protein microarrays while maintaining sensitivity and the need for
algorithms that are advanced enough to handle a protein array format.
One of the most important issues of implementing protein microarrays is the
difficulty in producing large numbers of highly pure recombinant proteins. However,
recent advances in protein complex purification involving the tandem affinity purification
method combined with RNAi (known as iTAP) by Forler et al. are a step in the right
direction (Forler et al, 2003). The sequence of the human genome may also help to
remediate this shortcoming by allowing the development of a perfectly normalized
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human cDNA clone library spanning the entire proteome. In fact, the FlexGene
Consortium has recently announced their mission to develop a complete cDNA collection
specifically for this purpose (Tyers and Mann, 2003).
New advances in nanotechnology may also help to overcome many of the
technical issues with the newly developing protein arrays. Some of these new advances
include the research of Ouyang and colleagues, who have demonstrated a soft-landing
mass-spec technique to separate protein mixtures and spot proteins in a microarray
format. An array of proteins was created by their soft-landing technique that allowed
proteins to retain their biological activity (Oyuang et al, 2003). Other advances in
nanotechnology that may assist protein array implementation include the development of
new protein capture agents, such as the mixed-element capture agents (MECAs)
developed by Bachhawat-Sikder and Kodadek. MECAs comprised of two small proteins
attached together with a variable linker region and were shown to bind their target
molecules with high affinity and sensitivity, making them good candidates for protein
array capture agents (Bachhawat-Sikder and Kodadek, 2003).
Despite the immaturity of peptide microarray technology, results from primitive
protein array assays have already indicated the usefulness and incredible versatility of the
assay. Analogous applications to those of DNA microarrays, such as using protein
profiling to obtain a characteristic fingerprint of a single disease, have already been
developed. In fact, protein microarray profiling has recently been used to fingerprint
different leukemia types, which may someday become a widely used diagnostic tool
(Service, 2003; Belov et al, 2001). In addition to fueling new research applications,
protein profiling could soon take its place next to the DNA microarray as a new
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diagnostic tool. Together with DNA microarray technology, peptide microarrays may
also help to revolutionize many aspects of the health care field, including applications to
diagnostics and assistance with the personalization of disease treatment.

Biosecurity and Bioterrorism
We have all probably noticed the increased attention focused on bioterrorism in
the United States since the attacks of September 11, 2001 and the subsequent reports of
inhalation anthrax in October, 2001 (Jernigan et al, 2001). Traditionally, biowarfare
research has mainly been conducted by military scientists in government facilities.
However, in 2003 alone, approximately $1.75 billion has been poured into biological
weapons research, much of which is being allocated to the private and academic sectors
to develop biowarfare research programs and facilities (Fauci, 2002). Biosecurity and
bioterrorism are a definite concern for the environmental health research community. In
response to the increasing threat of the use of biological and chemical weapons in a
terrorist attack, the Centers for Disease Control and Prevention (CDC) has compiled a list
of biological agents that would most likely be used in a terrorist attack (Rotz et al, 2002)
(See Table 1). The dissemination of aerosolized particles of many of these agents into
the environment is considered to be extremely dangerous. Therefore, it is the
responsibility of environmental health researchers to help develop new methods of
detecting chemical-biological (CB) agents and aide in the advancement of toxicology and
genetic interaction studies pertaining to novel vaccines and treatments.
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Preparedness in the Case of a CB Attack
In the past, emphasis has been placed on the ability of health care facilities to
communicate with each other and coordinate treatments in the event of a CB attack.
Such emphasis has prompted the development of many new training and preparedness
programs, including preparedness programs at the state and federal levels and nongovernmental professional programs, such as the Clinicians’ Biodefense Network (CBN).
The CBN aims to link clinicians to health experts and biomedical researchers, allowing
for rapid communication and the distribution of updated information concerning
biodefense during times of crisis (Radonovich, 2002). However, education and
preparedness of healthcare workers is not enough to protect the mass population.
Today, more emphasis has been placed on developing countermeasures in the
event of a biological attack, and there has been an overwhelming push by the government
and the public for further research into biosecurity efforts. It thus follows, that the
determination of the gene-environment interactions that can occur in response to
biological or chemical weapon attacks should be a major priority in the environmental
health research community. The development of rapid and standard laboratory tests
detecting exposure to a specific kind of CB agent that could be widely and economically
distributed to health care facilities would greatly enhance our ability for the early
detection and response to certain types of potential attacks. Candidate assays for these
tests include the identification of specific biomarkers for exposure to CB weapons.
Biomarkers could easily be assayed for changes in exposed victims and would greatly aid
in the early clinical recognition of such an attack. With the recent anthrax attacks, an
early screening method for potential biomarkers specific to anthrax infection applied to
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all who were suspected of anthrax exposure would have improved the ability of the
nation’s public health system to respond, and in turn could have possibly saved lives and
prevented the needless distribution of large amounts of Cipro (ciprofloxacin, the
antibiotic used to treat anthrax infections) (Jernigan et al, 2001; Rosenberg, 2003). With
the information gained from the completion of the human genome sequence, and the
multitude of emerging technologies available, there are many opportunities for the
exploration of bioterrorism countermeasures.

Preparedness in Case of a CB Terrorist Attack-Mass Vaccination
Many of the vaccines and treatments used to prevent the spread and disease
manifestations of potential bioterrorism agents were manufactured over 20 years ago; in
the case of the smallpox virus, the vaccine used to eradicate the disease in 1980 is the
only currently available vaccination (Lofquist et al, 2003; Fauci, 2002; WHO, 1980).
Previous data has suggested that a smallpox outbreak would spread slowly (Eichner and
Dietz, 2003). The current recommended public health response to a smallpox outbreak is
a ring vaccination strategy in which individual cases are isolated, quarantined, and their
contacts vaccinated (Whitley, 2003). However, some scientists have shown that this
approach may not be as effective as an immediate mass vaccination in the event of a
biological attack on an urban center (Kaplan et al, 2002), suggesting that new strategies
should be considered.
Several setbacks have surfaced during discussions concerning vaccination to
protect the mass population in the event of a biological attack. One of the most important
is the lack of interest from pharmaceutical companies to develop and produce vaccines
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for biological warfare agents. Most of the larger companies are unwilling to develop
these vaccines because of financial concerns, liability issues, efficacy questions, and
regulatory limitations (Rosenthal and Clifford, 2002; Langford and Myers, 2002).
Another concern is the high rate of complications in the vaccines that have been licensed
and are used exclusively in the military, but not in the general public. The high
occurrence of adverse effects in such a small population (reported to be >30% in some
instances) suggests that the benefits of vaccination in the case of a potential threat may
not outweigh the risks of vaccine complications (Frey et al, 2002). However,
identification of SNPs in certain populations via microarray analysis may help to
determine which subset of the population should not be vaccinated in preparation for a
biological attack. The identification of these individuals would result in a decrease in the
number of unnecessary complications/deaths that could occur in the event of a mass
vaccination, should a bioterrorism situation arise. Other measures would need to be
taken to protect these individuals. Although the United States currently has licensed
vaccines for smallpox and anthrax, it does not have these for many of the other agents
listed as potential biological warfare agents by the CDC and researchers are working
fervently to develop them (See Table 1). Newly developed Ebola vaccines have recently
been shown to protect mice, guinea pigs, and non-human primates from lethal doses of
the virus (Vanderzanden et al, 1998; Xu et al, 1998; Sullivan et al, 2000).
In addition to vaccination, other methods of preparedness have been discussed.
Recently, a set of guidelines has been published by the CDC’s National Institute for
Occupational Safety and Health (NIOSH), outlinining the procedures building officials
should follow to protect private, public, and government buildings from chemical,
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radiological, and biological terrorism (NIOSH, 2002). A second set of guidelines has
been published by the Office of Health and Safety to ensure laboratory security and
emergency response preparedness for laboratories that work with CB agents deemed fit
for terrorist attacks (Richmond and Nesby-O’Dell, 2002). In order to further protect
building environments from a CB attack, engineers have also been trying to develop a set
of biomaterials that can metabolize CB agents. The approach is designed to allow the
incorporation of these materials into equipment, such as the countertops of an office
building or the sorting machines used in post offices (reviewed in Russell et al, 2003).
The development of such materials combined with the protective measures outlined by
NIOSH and OHS could allow for widespread protection from attacks in almost any
building or environment, while diminishing public fear of an attack.

Early Detection of CB Agents in the Environment
Although much has been discussed concerning early disease recognition,
improved surveillance/communication methods, and the limitation of potentially sensitive
scientific information (Zilinskas and Tucker, 2002; Atlas et al, 2003; Chyba, 2001; Kwik
et al, 2003), less has been suggested concerning our ability to detect a CB attack before
clinical disease is recognized in victims. The early detection of the agent itself in the
environment, which could help prevent the spread of the infection in the case of a
biological attack and limit the number of victims affected by the agent, would be more
advantageous than the early detection of diseases caused by these agents.
One of the most effective ways to deliver a biological weapon is the release of
aerosolized particles into the environment. Implementing a biological agent monitoring
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system that can detect a CB agent by sampling the air would greatly enhance our ability
to evacuate enclosed areas deemed ideal for CB attack (Wyatt, 2002). Testing has
recently begun at San Francisco International Airport for one of the first CB agent
defense systems (Larkin, 2003). The system, known as PROACT (Protective and
Response Options for Airport Counter-Terrorism) and produced by Sandia National
Laboratories in Livermore, CA, is designed to monitor the air at large indoor public
meeting areas for CB agents as a measure to deter chemical attacks such as the 1995 sarin
attack in the Tokyo subway system (Frischknecht, 2003; Larkin, 2003). Details of the
mechanism of action of the device have not yet been disclosed. However, if it proves to
be reliable, the device may spread to other airports across the nation.
Immunological methods to detect biological warfare agents are also being
investigated for use in an early warning detection system. A miniature biochip system
based on an ELISA assay has recently been developed by Stratis-Cullum et al. In this
system, air samples containing aerosolized spores of Bacillus globigii were applied to a
minature ELISA biochip, where a novel alkaline phosphatase substrate,
dimethylacridinone phosphate (DDAO-P) was cleaved by an alkaline phosphatase (AP)
enzyme (Stratis-Cullum et al, 2003). The DDAO formed as a result of AP cleavage can
be excited by a miniature diode laser and the voltage output read on a laptop computer.
Although this highly sensitive, portable device was used for the detection of B. globigii
spores, it could be used to detect other aerosolized forms of biological weapons.
Another immunoassay, the multiplexed liquid array, has been shown to be useful
in the simultaneous detection of many different biological agents (McBride et al, 2003).
McBride and colleagues used a set of polystyrene microbeads conjugated to biowarfare

58

agent-specific antibodies, each of which displays a unique spectral pattern. Once the
microbeads are exposed to antigen, a secondary antibody conjugated to the fluorescent
reporter phycoerythrin (PE) is applied, and the beads are assayed in a flow cytometer.
The presence of the unique spectral pattern detects the type of antibody that reacted with
a biowarfare agent, while the PE is detected simultaneously to quantify the amount of
agent present in the air. These types of assays are candidates for use in early warning
detection systems because they are rapid, easily detected, and are part of a portable unit.

Environmental Health Research, the Human Genome Project, and Biosecurity
The DNA microarray and protein microarray applications discussed previously
can also be applied to bioterrorism. These techniques can be useful in leading us towards
unique physiological responses that may occur when an individual has been exposed to
these agents, providing scientists with a much narrower spectrum of therapeutic targets to
focus on during their research. The genomes of several potential biowarfare agents have
already been sequenced, including that of Bacillus anthracis (Read et al, 2003).
Microarrays have already been used to study the effects of the B. anthracis virulence
factors atxA and acpA. These studies suggest that atxA is a global regulator of many new
genes that could potentially exhibit virulence effects (Bourgogne et al, 2003). By treating
human protein arrays with a mixture of proteins from a biowarfare agent, one could infer
interactions between the proteins of the agent and human proteins, leading to new drug
targets, new signaling pathways, and new routes of infection. Implementing the use of
databases containing collections of array data would allow the expression effects of these
agents to be cross-referenced, possibly leading to the identification of a few candidate

59

therapeutic targets that could be used for the treatment of diseases induced by CB agents.
As suggested earlier, microarrays may also prove to be important in the identification of
novel or weaponized infectious agents. Microarrays played a large role in the
identification and characterization of the Severe Acute Respiratory Syndrome (SARS)
coronavirus that plagued China, Canada, and Vietnam, among others (Ksiazek et al,
2003). Additional applications include the use of microarrays to differentiate between a
large spectrum of possible viral infections and to determine the genotype of these
pathogens (Wang et al, 2002).

Novel Treatments in a CB attack
In addition to being concerned about preparedness in the case of an attack, novel
treatments of diseases caused by such CB agents should be thoroughly investigated. One
of the easiest ways to weaponize a bacterial strain for use in a biological warfare attack is
to engineer antibiotic resistance genes into the strain. Since this is not an extremely
difficult task, the need for non-antibiotic treatment of weaponized strains of biological
agents is an important matter. A novel approach to treating victims of a CB attack,
developed by Fischetti, is the use of purified bacteriophage lysins to specifically lyse
targeted bacteria, including those exhibiting antibiotic resistance. Fischetti’s group
demonstrated that PlyG, a gamma phage lysin specifically targeting B. anthracis,
effectively killed spores in vivo. PlyG treated mice had a 72% survival rate versus a 10%
survival rate for untreated mice (Fischetti, 2003). In addition to the bacterial lysin
approach, it may also be possible to deliver siRNA through a viral gene therapy
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mechanism as a therapeutic countermeasure to interfere with an agent’s ability to
replicate.

Future Directions
In order for scientists to get the maximum benefit from the current technology
available, significant technological and organizational improvements must be made.
Advanced software is required for bioinformaticians to accurately recognize common
binding domains, promoter regions, and transcriptional regulatory elements. The
development of user-friendly, organized databases providing DNA and RNA sequences,
protein interactions, protein structures with correct annotations, microarray data, and a
variety of animal genome sequences appear necessary to solve the puzzle of signaling
pathways, which can have profound effects on human disease states.
There are also many different forms of data that need to be explored on a multilevel scale. Genomes, transcriptomes, proteomes, and metabolomes are not separate
entities and each –omic level must be taken into consideration when integrating the
different types of information available. For example, many proteins are multi-functional
and may act at the level of transcription as well as participating in a cellular signaling
cascade. We must be able to view each piece of information from a global standpoint.
With the surge in the development of new techniques and fields of expertise, the
environmental health research community can use the information provided by the
genetic code to its advantage. The improved identification of environmentally hazardous
agents via gene and protein expression analysis as a diagnostic tool in health care
facilities could soon become a reality, allowing for better assessment of environmentally
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induced health risks and ultimately more accurate treatments. The elucidation of
biological responses to toxic environmental agents and the mechanisms by which these
agents cause cellular damage may aid in developing new drug targets and/or novel
therapeutic options. Transcriptome expression patterns could soon be identified for
individual toxicants and stressors, which may improve exposure assessment methods.
Additionally, the discovery of new biomarkers activated in response to environmentally
hazardous agents and the use of array expression analysis may soon be indispensable
tools for diagnosing a disease, determining its stage, predicting its course, and thus
dictating its treatment on an individual basis. The identification of susceptibility factors
through SNP screening could lead to a better assessment of risk factors for potentially
susceptible individuals and possibly even lead to prevention of adverse effects or even
some diseases altogether.

Concluding Remarks
In conclusion, the elucidation of a first draft of the human genome sequence has
provided the environmental health research community with a wealth of information and
a genetic framework that can greatly contribute to our understanding of geneenvironment interactions. Determining the actual extent of polymorphisms and assigning
function to the remaining 40% of predicted proteins with unknown molecular function
(Venter et al, 2001), are only a few examples of the challenges still ahead. However,
with the current information available and by using these new techniques and the
expertise of those involved in the emerging fields of environmental health research, we
can close in on our common goal of providing the world with better treatments and
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knowledge to prevent the atrocious diseases that can result from exposure to harmful
environmental factors.
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Figures and Tables
Figure 1: Webguide to Bioinformatics Sites and Useful Database Links
Bioinformatics Sites
HGP Timeline
Environmental Genome Project
NCBI Gene Expression Omnibus Database
FlexGene Consortium cDNA database
NCBI Genome Resources
University of Southern California Genome Bioinformatics
Cancer Genome Anatomy Project
HyperCLDB - Cell Line Database
Gene Ontology Consortium

http://www.ornl.gov/TechResources/Human_Genome/project/timeline.html
http://www.niehs.nih.gov/envgenom/home.htm
http://www.ncbi.nlm.nih.gov/geo
http://www.hip.harvard.edu
http://www.ncbi.nlm.nih.gov/genome/guide/mouse/
http://genome.ucsc.edu
http://cgap.nci.nih.gov
http://www.biotech.ist.unige.it/cldb/indexes.html
http://www.geneontology.org

SNP Sites
dbSNP
SNP Consortium Database
rSNP_Guide
Debbie Nickerson Lab SNP catalogs

http://www.ncbi.nlm.nih.gov/SNP
http://snp.cshl.org
http://www.mgs.bionet.nsc.ru/mgs/systems/rsnp/
http://droog.mbt.washington.edu

Proteomics and Structural Genomics Sites
Entrez Molecular Modeling Database
ModBase Database
Ann Stock Lab - Structural Genomics Links
Protein Structure Initiative
ExPASy Molecular Biology Server
RCSB Protein Data Bank
Danish Cancer Society - 2D Protein Database
Philip Andrews Lab - Proteomics Links
TRANSFAC - Transcription Factor Database

http://www.ncbi.nlm.nih.gov/entrez/query.gcfi?db=Structure
http://guitar.rockefeller.edu/modbase
http://stock.cabm.rutgers.edu/links/
http://www.structuralgenomics.org/
http://us.expasy.org/
http://www.rcsb.org/pdb/
http://proteomics.cancer.dk/
http://www.proteome.med.umich.edu/andrewslab/links/proteomics.html
http://www.gene-regulation.com/

Pharmacogenomics Sites
HGP – Pharmacogenomics
Pharmacogenomics and Pharmacogenetics Knowledge Base

http://www.ornl.gov/TechResources/Human_Genome/medicine/pharma.html
http://www.pharmgkb.org/index.jsp
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Toxicogenomics Sites
Toxicogenomics Research Consortium
National Center for Toxicogenomics Microarray Group
Toxicology and Environmental Health

http://www.niehs.nih.gov/dert/trc/home.htm
http://www.niehs.nih.gov/nct/nmc.htm
http://www.sis.nlm.nih.gov/Tox/ToxMain.html

Comparative Genomics and Systems Biology Sites
Harvard-Lipper Center for Computational Genetics
Princeton Model Organism Virtual Libraries
ENTELOS - Virtual Obesity Model
Virtual Heart Project

http://arep.med.harvard.edu
http://www.molbio.princeton.edu/scientific.php
www.entelos.com
www.physiome.org

Mouse Genome Informatics
Ensembl Mouse Genome Server
The Jackson Lab - Mouse Informatics
Harwell Mouse Informatics
RIKEN Mouse Informatics

http://www.ensembl.org/Mus_musculus/
http://www.informatics.jax.org
http://www.har.mrc.ac.uk/
http://genome.rtc.riken.go.jp/

Microarray Sites
The Brown Lab Microarray Database
Microarray Gene Expression Database (MGED)
Stanford Microarray Database
Microarray Gene Expression Data (MGED) Society
Telechem International E-Library
The Institute for Genimic Research (TIGR)
TIGR Microarray Software Suite
TIGR Gene Indices
TIGR Microarray Tools
MIAMExpress
The Churchill Lab Microarray Statistical Software
MIAME Checklist

http://cmgm.stanford.edu/pbrown/index.html
http://www.mged.org
http://genome-www5.stanford.edu/MicroArray/SMD
http://www.mged.org
http://arrayit.com/e-library/
http://www.tigr.org
http://www.tigr.org/software/tm4
http://www.tigr.org/tdb/tgi
http://pga.tigr.org/tool.shtml
http://www.ebi.ac.uk/miamexpress/
http://www.jax.org/staff/churchill/labsite/software/index.html
http://www.mged.org/Workgroups/MIAME/miame_checklist.html

SAGE and MPSS Sites
NCBI's SAGEmap
Arabidopsis MPSS Database

http://www.ncbi.nlm.nih.gov/SAGE/
http://mpss.udel.edu/at/java.html
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Table 1: CDC’s List of Potential Biological Warfare Agents1
Category A
Bacillus anthracis
Clostridium botulinum toxin
Yersinia pestis
Variola major (Smallpox)
Francisella tularensis
Viral Hemorrhagic fevers (i.e. Ebola,
Marburg, Lassa, and Machupo)

Category B
Brucella species
Clostridium perfringens ε-toxin
Food Safety Threats (i.e. Salmonella
species, E. coli O157:H7, and Shigella)
Burkholderia mallei
Burkholderia pseudomallei
Chlamydia psittaci
Coxiella burnetii
Ricin toxin
Staphylococcal enterotoxin B
Rickettsia prowazekii
Viral encephalitis (i.e. alphaviruses)
Water Safety Threats (i.e. Vibrio cholerae,
and Cryptosporidium parvum)

* Category C agents include any emerging infectious disease including
Nipah virus and hantavirus.
1

Adapted from the CDC website at www.bt.cdc.gov/agent/agentlist-category.asp
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SECTION III

Molecular mechanisms
of metal toxicity and carcinogenesis
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Abstract
Chronic exposure to many heavy metals and metal-derivatives is associated with an
increased risk of cancer, although the mechanisms of tumorigenesis are largely unknown.
Approximately 125 scientists attended the 3rd Conference on Molecular Mechanisms of
Metal Toxicity and Carcinogenesis and presented the latest research concerning these
mechanisms. Major areas of focus included exposure assessment and biomarker
identification, roles of ROS and antioxidants in carcinogenesis, mechanisms of metalinduced DNA damage, metal signaling, and the development of animal models for use in
metal toxicology studies. Here we highlight some of the research presented, and
summarize the conference proceedings.
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Introduction
The 3rd Conference on Molecular Mechanisms of Metal Toxicity and
Carcinogenesis was held at the National Institute for Occupational Safety and Health
(NIOSH) in Morgantown, West Virginia. Over 125 participants from 13 different
countries gathered at NIOSH to present their research on September 12–15, 2004. This
conference was the third meeting of metal researchers in the past 5 years, with previous
conferences convening in 2000 and 2002. Major areas of research emphasized at the
conference included metal epidemiology, identification of biomarkers, reactive oxygen
species (ROS) production, antioxidant effects, induction of DNA damage/lesions, metalinduced signaling pathways, and animal exposure studies. Here, we summarize the
conference proceedings and examine the future directions of research concerning the
molecular mechanisms that facilitate metal-induced carcinogenesis.

Epidemiological implications of metal exposure and the search for reliable biomarkers
Many metals are considered essential trace elements and must be present in low
concentrations in the human body in order for normal cellular function. However, altered
concentrations or transition states of metals in the body are thought to lead to a wide
range of deleterious conditions, especially an increase in cancer incidence. Increased
metal exposure in humans can occur via ingestion, inhalation, dermal contact, and
occupational exposure [1–4]. Although correlations between metal exposure and cancer
are well documented, more research is still needed in order to determine the exact
mechanisms of metal-induced carcinogenesis. Much of the metal toxicology and
carcinogenicity data available are acquired in animal model systems, with few studies
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representing the effects of metals in humans. Therefore, several groups at the conference
focused their research on the link between the level of metals in the human body and
carcinogenesis. Puneet and colleagues presented work examining the role of metals in
gallbladder carcinoma. Using atomic absorption spectrometry, they showed that the bile
of gallbladder carcinoma patients contained higher concentrations of cadmium (Cd),
chromium (Cr), and lead (Pb) than patients with other non-cancerous gallbladder
diseases, such as gallstones.
Additionally, Puneet’s group observed an increase in the expression of the metalexposure protection protein metallothionein (MT) in 70% of the gallbladder carcinoma
patients.

These results suggest that the body may concentrate these metals in the

hepatobiliary system and lead to gallbladder carcinoma. This group also examined the
lipid peroxidation profiles of gallbladder carcinoma patients in order to determine if a
free radical-induced mechanism might be involved. They found a significant increase in
the amount of a major lipid peroxidation product, 4-hydroxynonenal (4-HNE), in
gallbladder carcinoma patients compared to patients with other non-cancerous
gallbladder diseases. These results suggest that the formation of lipid peroxidation
products in the gallbladder, induced by metal exposure and free radical generation, may
be an underlying cause of tumorigenesis.
Many metals must be controlled by a tightly regulated homeostasis. Two such
examples are copper (Cu) and iron (Fe), the accumulation of which results in oxidative
stress-induced cellular damage [5, 6]. Wilson’s disease (WD) and primary
hemochromatosis (PH) are metal storage diseases which are associated with DNA
damage in the liver. In WD, a defect in a Cu-transporting ATPase results in the
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intracellular accumulation of Cu [7]. In PH, Fe accumulates in the liver because of a
mutation in the hfe gene, which is responsible for mediating the effects of the transferrin
receptor [8]. Patients with both WD and PH are shown to exhibit increased oxidative
stress-induced etheno-DNA adducts [9]. Vinyl chloride, urethane, and 4-HNE produce
etheno-DNA adducts as well [10–12]. These adducts can subsequently lead to the
formation of strong miscoding lesions and cause mutations and/or genomic instability in
patients suffering from WD and PH. Nair and Bartsch further examined the correlation
between the formation of 4-HNE-induced DNA adducts and susceptibility to the
development of liver cancer. They found that both WD and PH patients exhibiting high
4-HNE-induced DNA adducts were the most susceptible to the development of liver
cancer, particularly those patients suffering from PH.
Conversely, the dietary deficiency of many micronutrients, such as certain trace
metals, has also been associated with an increased risk of cancer [13–16]. Ansari et al.
presented data suggesting that significantly lower levels of selenium (Se) and zinc (Zn)
were found in the serum, biliary fluid, and gallbladder tissue of gallbladder carcinoma
patients when compared to healthy individuals. Serum manganese (Mn) was also reduced
in gallbladder carcinoma patients, leading Ansari’s group to conclude that a deficiency in
these trace elements is also associated with gallbladder carcinoma.
Since animal studies assessing the effects of metal exposure can often be difficult
to interpret and inconclusive due to the role of some metals as co-carcinogens, reliable
biomarkers are needed in order to assess metal exposure in humans. A good candidate for
a human biomarker must be specific to the effects of the causal agent and easily
quantitated and/or assayed for its presence in a noninvasive manner. Several studies
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presented at the conference examined the reliability of biomarkers for metal exposure.
Using atomic absorption spectrometry, Rahnama et al. analysed the Zn, Cu, Mn, and Fe
content of saliva and serum from patients with squamous cell carcinoma (SCC) of the
oral cavity. SCC patients exhibited increased concentrations of Cu, Mn, and Fe in their
blood and increased concentrations of all four metals examined in saliva when compared
to healthy individuals. These results suggest that analysis of saliva may be an easy and
effective way to detect SCC of the oral cavity.
In order to identify specific biomarkers of mercury (Hg) poisoning Song et al.
examined cases of peripheral neuropathy in Hg-exposed patients. Levels of selected
urinary proteins were measured in patients with acute or chronic Hg poisoning and
healthy control individuals. Elevated levels of the α1-m, β2-m, TRF, IgG, and NAG
proteins were observed in both acute and chronic Hg-exposed patients, suggesting that
urine samples may be a simple and inexpensive way to test for Hg exposure.
In addition to studying the adverse effects of metal exposure, it is important to try
to develop methods of exposure prevention. For example, Huang’s group attempted to
develop a correlation model between Fe exposure in coal mines and Coal Workers’
Pneumoconiosis (CWP). Fe is an essential trace metal that is stored in Fe-containing
proteins, such as ferritin and transferrin, where it is tightly bound and unavailable to
cause oxidative damage [17–19]. Bio-available iron (BAI), such as Fe associated with
citrate and ATP, has been shown to produce oxidants in a pH-dependent manner [20].
Some coal dusts contain BAI, and have been shown to activate the stress-inducible AP-1
and NFAT transcription factors, while coal dust lacking BAI had no effect on either
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transcription factor [21]. Previously, BAI content in Pennsylvanian coal was shown to be
much higher than the BAI content in coal dust originating from Utah [22]. Huang posited
that BAI content could be used as a predictor of coal toxicity. The BAI content of coal
from Utah and Pennsylvania was calculated and compared to epidemiological studies
reporting the incidence of CWP. A significant correlation was found between BAI levels
and CWP incidence, suggesting that BAI levels may be used to predict the toxicity of
coal before mining begins.
A second example of an in vitro predictive model for metal-induced disease was
introduced by Hockertz et al. Primary mast cells from human lung tissue and foreskin
specimens were exposed to wear particle antigens including chromium–cobalt–
molybdenum alloy (CrCoMo), a titanium alloy (TiAL6V4), or ultra-high molecular
weight polyethylene (UMHWPE), all of which can be released into the human body by
the degradation of implanted osseoprostheses [23]. Histamine release, indicative of an
allergic reaction, was observed when the antigens were added to serum-containing media
and applied to primary mast cells. If a patient’s IgE was present, histamine release
increased, particularly for the CrCoMo antigen. This in vitro model could be useful in
preventing potentially dangerous allergic reactions in patients with osseoprostheses and
reduce the need for the administration of immunosuppressants.
In some cases, a single biomarker candidate may be difficult to obtain and a
profiling-based approach may be useful in identifying a molecular fingerprint for toxicant
exposure. Boyd et al. presented an example of a high throughput strategy utilizing an
automated robotic workstation (COPAS BIOSORT) to dispense and measure the length
of Caenorhabditis elegans worms. Toxicological endpoints were examined using a
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fluorescent dye that only penetrates deceased worms. An imaging workstation was used
to track the motion of the live worms and acquire multidimensional image analysis data.
This type of high throughput method can be used to examine the properties of potential
neurological and developmental toxicants and detect subtle changes in gene or protein
expression that may be undetectable by conventional methods.

Balancing act: The role of reactive oxygen species (ROS) and antioxidants
Many transition metals have been shown to produce elevated amounts of
damaging ROS [24–28]. Disturbing the redox balance of a system leads to an increase in
DNA damage, DNA-protein crosslink formation, lipid peroxidation, apoptosis, cellular
toxicity, and/or the inappropriate activation of cellular signaling pathways [29–35]. Since
the mechanisms of ROS action are not well understood, many conference participants
focused their studies on the elucidation of these mechanisms. For example, Cr(VI) is a
transition metal that is known for its ability to produce increased quantities of ROS in
cellular systems, particularly •OH [36, 37]. Previous studies have focused on the effects
of soluble Cr(VI), since solubility is thought to be an important factor in its ability to
contribute to carcinogenesis [38]. However, water insoluble (or particulate) Cr(VI) has
also been shown to be genotoxic and cytotoxic [24, 39–41]. Leonard et al. examined the
capability of insoluble Cr(VI) in the form of PbCrO4 to produce ROS using electron spin
resonance (ESR) spectroscopy and the comet assay. Their results showed that insoluble
Cr(VI) was capable of producing oxidative stress in a similar pattern to that of soluble
Cr(VI).
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Additional studies examining the effects of PbCrO4 in the human lung cell line
WHTBF-6, were presented by Wise et al. PbCrO4 was shown to enter the lung cells and
exert clastogenic effects in a dose-dependent manner, although dicentric chromosome
formation was not observed. In order to exclude Pb ions as the culprits of clastogenicity,
HTBF-6 cells were also exposed to Pb-glutamate, which yielded no clastogenesis.
However, Na2CrO4 treatment also proved to be clastogenic in the lung cells, suggesting
that the CrO42- ions were the cause of clastogenicity. In addition, the antioxidant vitamin
C prevented the uptake of CrO42- ions and exhibited only a slight effect on Pb levels. The
cytotoxicity profiles of WHTBF-6 cells exposed to CrO42- ions and PbCrO4 were
comparable. Both PbCrO4 and Na2CrO4 induced cell cycle arrest and inhibited growth,
whereas Pb ions alone induced only mitotic arrest.
ROS production often leads to cell death through cytotoxicity and/or apoptosis,
prompting several groups to examine the benefits of inducing ROS in a cellular system
through metal treatment. Farmer et al. used synthetic melanins derived from dihydroxy
indole (DHI) to study the speciation, metal-binding affinity, and redox reactivity of those
synthetic melanins. Several metals bound the DHI-melanin, increasing redox cycling and
the production of •OH and O2•− surprisingly. Indium(III) ions alone and lipophillic
metallodithiocarbamate exhibited an unusual amount of toxicity towards melanoma cells
in culture.

The dithiocarbamate disulfide disulfiram (DSF), which is traditionally

prescribed as an alcohol-abuse deterrent, also showed strong Cu-dependent activity
towards melanoma cells. Cen’s group confirmed that DSF exhibited a Cu-dependent
toxicity towards melanoma cells, whereas nontransformed melanocytes were only
slightly affected. Upon DSF treatment, melanoma cell survival decreased to less than
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10% as the intracellular Cu concentrations increased. The addition of Cu chelators
blocked the DSF-induced cell toxicity and Cu uptake by melanoma cells. Formation of a
Cu(deDTC)2 complex was proposed to be the likely active agent. This response is unique
to Cu(II) and was not observed with Fe(II), Mn(III), or Zn(II), suggesting that local
administration of Cu and DSF or DHI may be useful in the treatment of melanoma.
Exposure to metal-containing particulates can also increase ROS production in
cellular systems. For example, diesel exhaust particles (DEP) have been shown to induce
DNA adducts and increase inflammation in the respiratory tract [42–46]. DEP contents
include polycyclic-aromatic hydrocarbons (PAHs), redox active semi-quinones, and trace
heavy metals [47, 48]. Park et al. compared ROS production of the DEP standard
reference material 2975 (SRM 2975) and DEP collected from the air in Korea as
measured by thiobarbituric acid – reactive substances of deoxyribose (TBARS).
Differences in transition metal composition were observed between samples; DEP from
Korea contained more Fe, less Cu, and less Zn than SRM 2975. TBARS measurements of
the water soluble fraction of SRM 2975 showed a broad absorption in the visible range,
which was absent in the DEP from Korea. Although SRM 2975 increased the amount of
TBARS fluorescence, H2O2 generated more TBARS in the DEP from Korea, probably
due to the increase in Fe composition. These results support a role for Fe in DEP-induced
H2O2 toxicity, which may be the underlying cause of the adverse health effects of DEP.
Some substances seem to exert both pro-oxidant and antioxidant effects. Recently,
many epidemiological and experimental studies have suggested that drinking green or
black tea may protect against cancer [49, 50]. Sinha et al. presented evidence suggesting
that

tea

extracts,

in

particular

the

polyphenolic

components,

exert

their
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chemopreventative effects by acting as antioxidants. They proposed that tea extracts can
prevent DNA damage caused by sodium arsenite in V-79 Chinese hamster lung
fibroblasts. However, Azmi et al. presented evidence that the presence of at least one of
those polyphenolic components, (−) epigallocatechin-3-gallate (EGCG), can induce
•

OH/O2•− formation and increase the rate of DNA oxidation in the presence of Cu ions.

The results of Azmi’s group suggest that EGCG’s apoptosis-inducing pro-oxidant
properties may be more important than its preventative antioxidant properties. These
studies are also supported by the findings of Qanungo et al. and Zykova et al. which
suggest that tea polyphenols may serve as either an antioxidant or an oxidant, depending
on the physiological environment [51–53].
Ascorbate/ascorbic acid/vitamin C is another compound that has been shown to
exhibit both pro-oxidant and antioxidant effects [54–58]. Huq and Hussain presented
evidence suggesting that exposure to Cd acetates increases DNA damage in the presence
of ascorbate. The mechanism occurs via the formation of a 1:1 covalent Cd(II)/ascorbate
adduct, causing a molecular activation of the transition metal. This group proposed that
the deprotonated ascorbate ions bind to 3O2 producing the volatile ROS species, singlet
molecular oxygen (1O2).
Ironically, some transition metals may serve as antioxidants and prevent oxidative
cellular damage. Aravind and Prasad presented evidence that Zn may be able to prevent
Cd toxicity. Ceratophyllum demersum L. plants were treated with different
concentrations of CdCl2 and/or ZnCl2. The production of •OH, an oxidative shift in GSH
levels, loss of carbonic anhydrase conformation, and DNA fragmentation were observed
with CdCl2 treatment. Upon treatment with both CdCl2 and ZnCl2, the presence of Zn
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inhibited all of the aforementioned markers of oxidative damage, suggesting that Zn may
be able to prevent the cytotoxic effects induced by Cd.
Rhenium is a second transition metal that exhibits low ROS-induced toxicity.
Thus, cluster rhenium compounds (CRCs) are thought to be a potential drug delivery
agent. CRCs possess lower toxic effects than other metals currently used as anti-tumour
agents, including palladium, platinum, and cisplatin [59]. Shtemenko and Shtemenko
examined the mechanisms of lipid-CRC interactions in solution and during the formation
of liposomes. They had previously shown that CRCs bind to carboxylic acids, amino
acids, or adamantanic acids, and subsequently interact with the surface of red blood cells
to stabilize the membrane in response to free radicals [60]. Administration of CRC1dichlorotetra-μ-(i-butirato) dirhenium(III) or CRC2-tetrachlorodi-μ-(γ -aminobutirato)
dirhenium(III) chloride in models of hemolytic anemia led to an increase in hemoglobin
and resistance of erythrocytes to oxidative stress, extending the life of hemolytic animals.
In addition, CRC1 or CRC2 administration increased reduced glutathione pools,
glutathione reductase expression, and glutathione peroxidase (GPx) expression in the
tissues of animals with hemolytic anaemia. Thus, CRCs demonstrate antioxidant and
antiradical properties in vivo and may be useful in the treatment of hemolytic anaemia.
Cellular systems have developed a wide range of antioxidant mechanimsms to
combat the dangerous accumulation of ROS. Examples include the increased expression
of ROS detoxification enzymes, such as catalase and superoxide dismutase (SOD), and
the maintenance of pools of small molecular ROS scavengers, such as N-acetyl-cysteine
(NAC) and reduced glutathione (GSH). These ROS scavenging molecules react with
excess ROS, thus minimizing cellular damage. Glutathione (GSH), although widely
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known for its antioxidant activity, is also involved in Se metabolism and bioactivity [61].
Shen et al. presented evidence that Se caused a dose-dependent onset of mitochondrial
permeability transition (MPT) in the presence of GSH, which could be inhibited by the
MPT inhibitor cyclosporin A. An SOD mimic, Mn[III]tetrakis [4-benzoic acid]
porphyrin, has been previously shown to prevent MPT caused by xanthine (X)–xanthine
oxidase (XO) [62]. Surprisingly, SOD had no effect on MPT and was unable to prevent
the reduction of cytochrome c induced by selenite-GSH (Se-GSH) formation. Although
others have observed an increase in O2•− formation during Se-GSH generation, Shen’s
group measured O2•− via the lucigenin assay and found no significant increase in O2•−
when compared to O2•− production by the X–XO pathway [63]. These results suggest that
O2•− is not responsible for Se-GSH-induced MPT in this system.
Resveratrol is a polyphenolic antioxidant that is synthesized by many plant
species and has been shown to inhibit the growth of cultured cancer cells [64]. Xia et al.
presented evidence that ROS-induced activation of the PI3K/Akt survival pathway can be
inhibited by the presence of resveratrol in prostate cancer cells. Resveratrol also inhibited
the expression of proteins involved in angiogenesis, such as HIF-1α and VEGF, in a
dose-dependent manner. Xia’s results suggest that resveratrol may be able to inhibit
prostate cancer progression and angiogenesis through the inhibition of these pathways.

DNA damage/lesions and mitotic effects
In addition to producing ROS, many metals have been shown to directly modify
and/or damage DNA by forming DNA adducts, facilitating DNA protein crosslink
formation, or inducing chromosomal breaks [33, 44, 65, 66]. Many researchers at the
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conference presented work reflecting efforts to identify the mechanisms of metal-induced
DNA damage. For example, O’Brien et al. examined the role of O2 in Cr(VI)-induced
DNA lesions and found that hypoxic conditions did not alter Cr(VI) reduction by
ascorbic acid. However, both Cr(VI)-DNA binding and the occurrence of polymerase
arresting lesions (PALs) decreased under hypoxic conditions by 70% and 50–90%,
respectively. These results suggest that O2 can help facilitate the formation of Cr(VI)DNA complexes.
A

common

oxidative

DNA

modification,

the

7,8-dihydro-8-oxo-2_-

deoxyguanosine (8-oxo-dG) lesion, can lead to the misincorporation of extraneous
nucleotides during DNA replication [67, 68]. The 8-oxo-dG lesions are prone to further
oxidation by many transition metals, including Cr(V) and Iridium (IV). Further oxidation
of

8-oxo-dG

leads

to

the

formation

of

guanidinohydantoin

(Gh)

and

spiroiminodihydantoin (Sp) lesions, subsequently causing G→T and G→ C transversions
[69, 70]. Gh and Sp lesions are thought to enhance base misincorporation and the
polymerase blocking effects of the 8-oxo-dG lesion [71, 72]. Certain base excision repair
(BER) enzymes recognize 8-oxo-dG lesions, but not Gh or Sp lesions [73, 74]. Hailer et
al. showed that the mammalian BER glycosylases NEIL1 and NEIL2 both recognize and
cleave Gh and Sp lesions in single-stranded DNA [75]. These results demonstrate that an
alternative pathway is activated in response to the formation of Gh and Sp DNA lesions.
The 8-oxo-dG lesion also affects transcription factor binding [76, 77]. Previous studies by
Sugden’s group reported that binding activity of the NF-κB p50 subunit increases if
the G1 nucleotide of the NF-κB consensus binding sequence (5’-dAGTTGA
G1G2G3G4ACTTTCCCAGCC-3’) is replaced with an 8-oxo-dG modified base [77]. In
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contrast, replacing the G3 nucleotide with an 8-oxo-dG decreases p50 binding activity.
Sugden et al. found that p50 binding activity to the modified NF-κB consensus sequences
correlated with p50 in vitro transcription activity, providing a direct link between the
regulation of gene transcription and ROS formation.
In addition to inducing DNA lesions, metals can interfere with cellular processes
such as mitosis. Kligerman et al. presented evidence that arsenicals induced c-type
anaphases consisting of small, condensed chromosomes – an effect usually seen with
spindle poisons [78]. They proceeded to investigate the effects of several different
modified arsenicals on mitosis and found that monomethylarsenous acid (MMAIII)
exhibited the most potent mitotic interference. When tubulin was directly exposed to
MMAIII, an increase in the number of mitotic indices (MIs) was observed. None of the
arsenicals with a valence state of V showed an obvious effect on tubulin polymerization,
whereas all arsenicals with a valance state of III inhibited tubulin polymerization. Taken
together, these results indicate that As(III) and its metabolites can interfere with cell
division.
Activation of DNA repair enzymes is often observed in response to metal-induced
DNA damage [79–81]. Lee et al. examined the effects of DNA repair gene
polymorphisms on the number of Cr(VI)-induced strand breaks in human white blood
cells. Several DNA repair genes with known genetic polymorphisms were examined,
including glutathione S transferase M1 (GSTM1), glutathione S transferase T1 (GSTT1),
NADPH quinine oxidoreductase 1 (NQO1), X-ray repair cross complementation factor
1 (XRCC1), and the 8-oxo-7,8-dihydroguanine (8-oxo-G) DNA glycosylase (OGG1).
White blood cells homozygous for the OGG1 Cys326 polymorphism exhibited an
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increased number of DNA strand breaks when compared to the OGG1 Ser326/Ser326 and
OGG1 Ser326/Cys326 polymorphisms. White blood cells homozygous for the OGG1
Cys326 variation also exhibited an increase in the ratio of oxidative DNA damage to
plasma antioxidant capacity. These results suggest that OGG1 Cys326 homozygous
individuals may be defective in the repair of DNA adducts during oxidative stress
conditions, possibly due to the oxidation of these residues.

Metal-induced cellular signaling
Although each metal activates its own unique set of signaling events, many metals
also activate general ROS-mediated stress response pathways. DNA microarray
technology has recently been used to examine the global effects of metals in several
model systems. For example, Jin et al. examined the global transcriptional response of
the yeast Sacchromyces cerevisiae to Zn, Cd, Hg, Cu, silver (Ag), Cr, or arsenic (As)
exposure. Approximately 25% of the yeast genes were affected by at least one metal (798
upregulated genes and 774 downregulated genes). Most of the metals upregulated genes
involved in the oxidative damage process, sulfur assimilation, sulfur metabolism, and
GSH biosynthesis. Genes encoding biomolecular transporters of sugar and lipid
metabolism were downregulated. Approximately 10% of the total number of S. cerevisiae
genes were affected by As treatment – a 2–5-fold increase in the number of genes
affected by any other metal examined. Additional classes of genes induced by As
treatment included double-stranded break (DSB) repair and DNA replication genes.
Other examples of the use of microarray analysis in toxicology studies included
Song and Freedman’s examination of the global transcriptional effects of Cu treatment on
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a human hepatoma cell line, Hep2G. After 4 h of Cu exposure, 42 genes were
upregulated and 24 were downregulated. The upregulated genes included metallothionein
IIA (MT2A), myosin heavy polypeptide (MYH8), CYP1A1, IL-1 receptor alpha
(IL11RA), heat shock protein A1A (HSPA1A), and heme oxygenase 1 (HO-1).
Downregulated genes included the HT017 protein, dynamin 1-like (DNM1L), DEAD box
polypeptide 18 (DDX18), and GST theta 2 (GSTT2).

RT-PCR confirmed the

upregulation of HSPA1A, CYP1A1, and HO-1 with peak induction levels at 12, 24, and 8
hours respectively.
Many of the global effects of metals on transcription are thought to be controlled
by the interactions between metal response elements (MREs) and MRE binding
transcription factors such as MTF-1 [82]. Since PKC inhibitors can abrogate MT
induction, it is thought that some metals induce signaling cascades through PKC
activation, subsequent alteration of MTF-1 phosphorylation, and activation of MT
transcription [83]. Craft and Freedman examined the role of p53 activation in MT
induction by Hg and Cd and found MT transcription was reduced in p53 −/− cells when
compared to wild-type p53 cells. These results suggest that p53 may be part of a general
mechanism in the cellular response to both Hg and Cd exposure.

Arsenic signaling
After a metal ion is transported across the cytoplasmic membrane, its transition
state is often altered by cellular reducing agents. Reduction of some metals to a lower
transition state, such as As(V)→As(III), often results in an increase in toxicity; thus it is
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beneficial to examine the metal’s cellular point of entry. The ArsATPase is a catalytic
subunit of the Escherichia coli ArsAB pump that translocates As(III) across the cellular
membrane, conferring resistance to arsenicals and antimonials [84, 85]. There are two
halves of the Ars ATPase, A1 and A2, each consisting of a nucleotide binding domain
(NBD) and a metal binding domain (MBD). The NBD and MBD are connected by two
amino acid linkers which serve as a signal transduction domain [85, 86]. Using sitedirected mutagenesis, Bhattacharjee and Rosen altered residues of the signal transduction
domain and found that the D142A and P145A mutations caused a loss of As(III)
resistance. These results indicate that this domain is important in the signaling events
between the catalytic and allosteric sites of the Ars ATPase. The aquaglyceroporin (AQP)
family is responsible for the uptake of As(III) and Sb(III) in humans [87, 88].
Mukhopadhyay et al. reported that overexpression of human AQP9 in the chronic
myelogenous leukemia cell line K562 increased uptake of the As(III)-based drug
Trisenox [89]. Since AQP9 overexpression in K562 cells exhibited hypersensitivity to
Trisenox, it is possible that pharmacological alteration of AQP9 expression could boost
Trisenox effectiveness in cancer patients.
As(III) induces oxidative stress and delays cell cycle reentry into the G1 phase by
an unknown signaling mechanism [90, 91]. Chen et al. presented evidence that As(III)
induces ubiquitination and subsequent degradation of the Cdc25C protein, a protein
which is thought to cause the exit of cells from the G2/M phase [92]. These effects were
not abrogated by treatment with antioxidants. Furthermore, immunoprecipitation showed
that Cdc25C associates with the Fzr/Cdh1 recognition subunit of the mitotic APC
ubiquitin ligase complex. siRNA silencing of Fzr/Cdh1 expression protected Cdc25C
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from degradation and decreased ubiquitin conjugating activity. Chen’s group concluded
that As(III) induces the redox-independent ubiquitination and degradation of Cdc25C
through its association with Fzr/Cdh1.
As(III) exposure also induces remodelling of the cytoskeleton [93]. Qian et al.
demonstrated that As(III) activated Cdc42 and NADPH oxidase. Activated NADPH
oxidase produced O2•− and induced actin filament reorganization in SVEC4-10 cells [94].
Overexpression of a dominant negative Cdc42 or treatment with the actin filament
stabilization agent jasplakinolide inhibited actin filament reorganization and prevented
NADPH oxidase activation. Qian’s group concluded that As(III) activates NADPH
oxidase through Cdc42 and leads to actin filament reorganization and the formation of
lamellipodia and filopodia. These effects could possibly lead to increased cell migration
and/or metastasis of As(III)-induced tumors.
Paradoxically, As also exhibits apoptotic-inducing effects. Ivanov and Hei
presented evidence that human melanoma cells exposed to combinations of low
concentrations of As (2–10μM) and EGFR, PI3K/Akt, or MEK/Erk inhibitors effectively
induced apoptosis via the TRAIL and TNFα pathways in spite of low Fas levels [95]. The
combination of As and synthetic small molecule inhibitors could potentially be used to
sensitize melanoma cells to cytotoxic drugs, enabling the development of more effective
chemotherapy regimens.
Lemarie et al. further examined the apoptotic pathway induced by As and found
that As2O3 prevented monocyte adhesion and expression of the macrophage phenotypical
markers transferrin receptor CD71 and integrin CDIIc. As2O3 induced monocyte
apoptosis, increased caspase 8 and caspase 3 expression, decreased cFLIP and XIAP
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expression, decreased NFκB binding activity, and exhibited a loss of mitochondrial
membrane potential. Lemarie’s group suggested that As2O3 may induce apoptosis by
inhibiting NFκB activity and subsequently decreasing the expression of the cFLIP and
XIAP pro-survival proteins, both of which are transcriptionally controlled by NFκB.
Taken together, these studies may provide insight into the signaling pathways responsible
for As’s ability to induce apoptotic effects as well as carcinogenic effects.

Chromium signaling
Cr(VI) has been known to produce ROS, induce DNA damage, and subsequently
activate the ATM, p53, and Chk2 proteins [96, 97]. It is known that ATM is activated
specifically in response to DSBs, however no Cr-induced DSBs have been reported [98–
101]. Ceryak et al. exposed normal human dermal fibroblasts to Cr(VI) or the
radiomimetic agent neocarzinostatin (NCS) and analysed the occurrence of DSBs, the
phosphorylation status of histone H2A.X (γ -H2AX), and the formation of γ -H2AX
nuclear foci. Their evidence suggested that DSBs were formed in response to Cr(VI)
exposure in an S phase-dependent manner, while NCS exposure exhibited an equal
distribution of DSB formation throughout all phases of the cell cycle. Additionally,
Cr(VI) exposure showed γ -H2AX foci formation in PCNA positive cells; an effect that
was absent in the NCS-exposed control cells and decreased in ATM−/− cells.
Xie et al. independently showed that PbCrO4 induced DSBs in a dose-dependent
manner, resulting in the activation of ATM in human lung cells. γ -H2AX is rapidly
phosphorylated on Ser139 when DSBs are induced by ionizing radiation [102]. Xie’s
group also showed that PbCrO4 induced a concentration-dependent phosphorylation of γ -
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H2AX and subsequent foci formation. Taken together, these results demonstrate a
general mechanism for Cr(VI)-induced carcinogenesis involving the induction of S
phase-dependent DSBs and marked by γ -H2AX foci formation.
Xu presented additional evidence that Cr(VI) exposure activates ATM/ATR,
phosphorylates the structural maintenance chromosome 1 (SMC1) protein, and activates
caffeine sensitive S phase cell cycle arrest in a dose-dependent manner. Surprisingly,
Cr(VI)-induced S phase cell cycle arrest was shown to be independent of ATM at high
concentrations. Xu proceeded to examine alternate pathways responsible for Cr(VI)induced S phase cell cycle arrest and found that Rad17, which is required for the release
of active ATR, bound the site of Cr(VI)-induced DNA damage. A non-functional Rad17
showed impaired S phase arrest in response to Cr(VI) exposure, suggesting that a low
dose of Cr(VI) activates an ATM-dependent pathway, whereas a high dose of Cr(VI)
activates an ATR-dependent pathway.

Cadmium signaling
The activation of transcription factors by metals is one of the most commonly
studied effects of metal-induced cellular signaling. However, recent interest has been
expressed in alternative targets of metal signaling, such as the translational machinery
pathways. Aberrant regulation of the expression of the translational control proteins eIF3
and eEF1δ has been shown to be responsible for Cd(II)-induced transformation and
tumorigenesis [103, 104]. Orthumpangat et al. presented evidence that a third
translational control protein may also affect the cellular response to metals. Cell lines
exposed to Cd(II) exhibited a decrease in eIF4E protein expression. siRNA silencing of
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eIF4E induced cell death, whereas eIF4E overexpression resulted in cell survival after
exposure to an otherwise lethal dose of Cd(II). Cd(II) exposure also activated the
ubiquitin pathway, resulting in the degradation of eIF4E and a subsequent decrease in
cyclin D1 expression.
The expression of other members of the translational machinery family were
altered upon exposure to Cd(II). One such protein, eEF1A2 is a cellular proto-oncogene
which is overexpressed in many cancer cell lines and tumors. Orthumpangat’s group
reported that eEF1A2 expression was increased in response to Cd(II), while
overexpression of eEF1A2 conferred resistance to Cd(II)-induced apoptosis. These
results confirm that the translational machinery is a potential mechanism for Cd(II)induced carcinogenesis.
Hep3B human hepatocarcinoma cells have been shown to undergo Cd-induced
apoptosis in a caspase-independent manner [105]. The mechanism is thought to involve
the nuclear translocation of endonuclease G (endoG) and the apoptosis-inducing factor
(AIF), both of which are mitochondrial apoptogenic proteins. Lemarie et al. showed that
the release of endoG and AIF in response to Cd exposure was preceded by an increase in
cytoplasmic Ca2+ and a loss of mitochondrial membrane potential. Bapta-AM, a Ca2+
chelator, blocked these events and prevented apoptosis. Inhibition of ROS production by
the mitochondrial inhibitors ruthenium red, rotenone, and diphenyleneiodonium
prevented

the

loss

of

mitochondrial

membrane

potential.

Bapta-AM

and

diphenyleneiodonium also blocked expression of the NFκB-regulated anti-apoptotic
protein bcl-x(L) in Cd exposed cells. Lemarie’s group concluded that Cd induces
apoptosis in Hep3B cells through Ca2+ release and ROS-induced impairment of the
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mitochondria. These results are in agreement with the hypothesis that Cd-induced
apoptosis occurs through the release of endoG and AIF.

Cobalt and copper signaling
Exposure to the hard metal dust tungsten carbide–cobalt mixture (WC–Co)
directly correlates with an increased risk of cancer in exposed workers [106]. Lombaert
et al. demonstrated that both cobalt (Co) and WC–Co induced apoptosis of peripheral
blood mononucleated cells (PBMCs). WC–Co apoptosis occurred at a higher rate than
Co-induced apoptosis and was dependent on caspase 9 activation, whereas Co-induced
apoptosis depended on the activation of both caspases 8 and 9. These results demonstrate
that although WC–Co and Co can produce similar cellular effects, the signaling
mechanisms may be different.
Although Cu is a trace element necessary for the function of enzymes such as
SOD, it can also produce ROS, DNA damage, and other carcinogenic effects when
present in excess. Cherian and Ostrakhovitch examined the effects of Cu exposure on the
p53 tumour suppressor signaling pathways in the breast cancer epithelial cell lines MDAMB-231 and MCF7. p53 mutant MDA-MB-231 cells are resistant to metal toxicity, while
p53 wild-type MCF7 cells are sensitive to metal-induced apoptosis [107, 108]. ROS
production was not observed in MDA-MB-231 cells exposed to Cu; however, an increase
in Akt phosphorylation, Akt nuclear translocation, Cyclin D1 expression, and cell cycle
progression were still apparent. In contrast, ROS production in MCF7 cells increased in
response to Cu exposure. Increases in p53 expression, p21 expression, G1 phase arrest,
and apoptosis in MCF7 cells were also observed. Additionally, Cu-exposed MCF7 cells
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exhibited a loss of mitochondrial membrane potential and lacked Akt activation and
translocation. Suppression of p53 in MCF7 cells with pifithrin or E6 protein decreased
p53 phosphorylation and increased Akt phosphorylation, suggesting that p53 is involved
in the response to Cu-induced ROS formation [109].

Nickel signaling
Insoluble nickel (Ni) compounds, such as Ni3S2, green NiO, black NiO, and Ni
refinery dust, have been shown to exert carcinogenic effects in a variety of animal
experiments [110]. Landolph et al. showed that Ni3S2, green NiO, and black NiO are
phagocytosed by C3H/10T1/2 mouse embryo cells. Cytotoxicity, chromosomal
aberrations, and morphological transformation were observed upon Ni exposure. The
extent of phagocytosis was shown to correlate with each Ni compound’s ability to induce
transformation. RAP-PCR differential display experiments showed 130 genes that were
differentially expressed between the Ni-transformed and nontransformed cell lines.
Increased expression of the ect-2, calnexin, and wdr1 genes in transformed cells were
confirmed by Western blot. Respectively, these genes encode a Rho GDP/GTP exchange
factor that modulates microtubule assembly, a molecular chaperone, and a stressinducible protein. Decreased expression of the vitamin D receptor interacting
protein/thyroid hormone activating protein 80 (DRIP/TRAP-80) and two other novel
genes was also observed in transformed cells. Landolph’s group concluded that Ni ions
generate ROS, mutate and activate proto-oncogenes and/or tumour suppressor genes, and
also induce chromosomal aberrations.
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Paradoxically, Ni can upregulate the expression of some genes while
downregulating others, possibly through the post-translational modification of histones.
Ni suppresses the acetylation of core histones H3 and H4 and induces de novo DNA
methylation, leading to gene silencing [34,111]. Costa’s group found that water-soluble
Ni salts could inhibit the acetylation of the core histones H2A, H2B, H3, and H4. Ni
exposure also induced methylation of Lys 9 in histone H3 and increased the
ubiquitination of histones H2A and H2B. Golebiowski and Kasprzak also examined the
acetylation status of the N-terminal tails of the core histones in Ni-exposed human and
rodent cells exposed to Ni(II). Histone H2B exhibited the least acetylation, followed by
histones H4, H3, and H2A in human airway epithelial cells and normal rat kidney cells.
However, these effects were not seen in Chinese hamster ovary (CHO) cells, suggesting
that the decrease in acetylation may be cell-type dependent. Ni(II) has been shown to
cleave the –SHHKAKGK motif of the C-terminal tail of histone H2A in vitro and in cell
culture [112, 113]. Karaczyn et al. examined the effects of Ni(II) on other histones and
showed that histone H2B abundance increases with Ni(II) treatment over time. Mass
spectrometry and amino acid sequencing analysis confirmed that the H2B
immunoreactive bands were variants of histone H2B. The larger band represented a
truncated histone H2B lacking 16 amino acids from the N-terminal tail. The smaller band
represented a histone H2B variant lacking both the 16 N-terminal amino acids and an
additional nine amino acids from the C-terminal tail. Post-translational modifications of
the smaller band included two acetylated Lys residues. Similar, but weaker effects on
histone H2B were seen with Co(II), but no effects were seen with Cu(II), Cd(II), or
Zn(II). Since the terminal tails of histones are thought to play key roles in structuring
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chromatin and regulating gene expression, the loss of these regions may be involved in
the mechanisms relating to Ni(II)-induced carcinogenesis. Taken together, these results
suggest that histone modification may play a major role in the mechanism of Ni-induced
gene activation and/or silencing.
In addition to modifying core histones, Ni-exposure also activates the HIF-1α
transcription factor via the depletion of intracellular Fe and the subsequent inhibition of
the Fe-dependent enzyme proline hydroxylase, which leads to the stabilization of HIF-1α
[114]. Huang et al. examined the effects of Ni3S2 or NiCl2 exposure on other transcription
factors and found that Ni ions increased ROS production and activated NFAT. NFAT
activation was inhibited by catalase, NAC, and desferoxamine (DFO), but not by SOD or
sodium formate. Ni activation of the HIF-1α, PI3K, Akt, and p70S6K
was abrogated by PI3K inhibitors. Overexpression of Akt and PI3K dominant negative
(DN) mutants also inhibited HIF-1α activation and Cap43 expression, while exposure to
rapamycin, a p70S6K inhibitor, had no effect. In conclusion, Huang’s group suggested
that Ni generates H2O2 which in turn activates NFAT. HIF-1α and Cap43 are also
activated by Ni via a PI3K/Akt-dependent pathway, independently of p70S6K activity.

Animal studies
Although animal studies provide valuable information concerning the toxic
effects and signaling pathways of environmental contaminants, adequate animal models
do not exist for some metals due in part to their roles as co-carcinogens. Thus, it is
difficult to assess the effects of the metal itself because a known carcinogenic compound
must be administered simultaneously in order for a tumour to develop. For example,

114

Burns et al. presented evidence that hairless mice (Skh1strain) exposed to ultra-violet
radiation (UVR) and Cr- or As-contaminated drinking water elevated the number of
tumors produced by UVR to 8.3- and 4.6-fold, respectively. These data confirm that
metals can act as hazardous co-carcinogens even at low levels of exposure.
Most metal toxicity studies have been conducted on adult animals, yet few have
focused on the effects of metal exposure during the pubescent period. Chatterjee et al.
examined Sprague–Dawley rats exposed to intravenous-infused CdCl2 40–100 days after
birth. Histopathological examination of the mammary tissue showed that Cd(II) exposure
slightly suppressed apoptosis while DNA strand breaks increased by 61%. At low doses,
no change in histopathology of the mammary tissue was observed. However, at high
doses, exposed rats exhibited intraductal proliferations. In addition, MT expression was
elevated 60–86% in Cd(II)-treated animals in a dose-dependent manner. These results
indicate that Cd(II) exposure may lead to an increased incidence of cancer in pubescent
animals.
Additionally, Chatterjee et al. examined the chemopreventive effects of vanadium
(V) supplementation. Rats were exposed to diethlnitrosamine (DEN) and phenobarbitol
to induce hepatocarcinogenesis, and subsequently fed V-supplemented chow for 20
weeks. V supplementation reduced the nodular incidence, total number of tumors, and
multiplicity of tumors, and decreased metallothionein expression, BrdU labelling index (a
marker of cell proliferation), and iNOS expression. In addition, V supplementation
increased p53 immunoreactivity and the apoptotic labeling index. These results suggest
that V may play a significant role in controlling cellular activities during chemicalinduced hepatocarcinogenesis.
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Depleted uranium (DU) is a radioactive heavy metal used to manufacture military
munitions. United States military personnel wounded by DU shrapnel may have a higher
risk of cancer incidence, due to DU’s genotoxic and mutagenic effects [115, 116]. DU
can also cause radiation-specific cellular damage and transformation of human osteoblast
cells [117, 118]. In order to simulate the effects of a DU-containing shrapnel wound,
Miller et al. implanted non-tumourigenic immortalized cells into syngenic DBA/2 mice
with or without DU implantation pellets. Mice implanted with DU pellets showed an 80%
incidence of tumorigenesis, whereas control mice exhibited a 10% incidence of leukemia,
suggesting that DU can significantly enhance tumour incidence.
Chromium(III) Picolinate (Cr(Pic)3) is a dietary supplement associated with
oxidative damage, DNA damage, antioxidant enzyme depletion, and renal/liver
dysfunction in rats [119, 120]. In cell culture, Cr(Pic)3 has been shown to cause mutations
and DNA fragmentation [121]. Rasco et al. examined the prenatal effects of dietary
supplementation of Cr(Pic)3, CrCl3, or picolinic acid in pregnant female mice. The
fetuses birthed from the Cr(Pic)3-fed females showed an increase in bifurcated cervical
arches, delays in righting reflex, delays in hind limb grasp, and deficiencies in motor
skills. These results demonstrate that dietary supplementation of Cr(Pic)3 exerts negative
effects on the developing nervous system of mammalian fetuses.
Barchowsky et al. developed an animal model to examine the effects of As(III) on
angiogenesis and the expression of tissue remodelling genes in cardiac tissue. Male mice
were exposed to As(III)-contaminated drinking water at low to moderately high
concentrations for up to 20 weeks. Enhanced vascularization of Matrigel implants was
observed after 5 weeks of As(III) exposure. RT-PCR showed a dose and time-dependent
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induction of VEGF, VEGF receptors, plasminogen activator inhibitor-1, endothelin-1,
and matrix metalloproteinase-9 in cardiac tissue. Barchowsky’s group concluded that the
effects of chronic As(III) exposure on the cardiovascular tissue varies with dose and
length of exposure.

Summary
The research presented at the 3rd Conference on Molecular Mechanisms of Metal
Toxicity and Carcinogenesis provided new insights into the mechanisms of ROS
production, the mechanisms of metal signaling, and the development of animal exposure
models. However, the following areas of metal research still need further exploration.
First, there is a need for the development of new human biomarkers for metal exposure.
Without definitive and specific biomarkers, it is very difficult to assess the extent of
metal exposure in humans, and thus, difficult to treat the resulting ailments. Second, since
most metals cause some form of ROS-induced cellular stress, the elucidation of the
mechanisms of ROS production may provide information concerning the general
mechanisms of metal-induced carcinogenesis. Third, defining the mechanisms of metalinduced DNA damage may provide new insights into the signaling events involved in
DNA damage repair pathways. Fourth, a better understanding of the complex signaling
networks that lead to the adverse effects of metals could lead to the identification of
superior and more specific novel therapeutic agents. Finally, better animal models for
metal exposure are necessary in order to thoroughly evaluate the toxic and carcinogenic
effects of metals in a model system. Through the use of current technology and the
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implementation of new experimental strategies, metal researchers can address these
concerns.
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SECTION IV
As(III) transcriptionally activates the gadd45a gene via the
formation of H2O2
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ABSTRACT:
Arsenic is a ubiquitous environmental contaminant associated with an increased risk of
human cancers of the skin, lung, bladder, and prostate. Intriguingly, it is also used to
treat certain types of leukemia. It has recently been suggested that these paradoxic
effects may be mediated by arsenic’s ability to simultaneously activate DNA damage,
apoptotic, and transformation pathways. Here, we investigate the effects of arsenic
exposure on the induction of the growth arrest and DNA damage protein 45α
(GADD45α), which is thought to play roles in apoptosis, DNA damage response, and cell
cycle arrest. We found that arsenic transcriptionally activates the gadd45α promoter
located in a 153 base pair region between -234 and -81, relative to the transcriptional start
site. In addition, this transcriptional induction was abrogated in the presence of H2O2
scavengers, suggesting a role for H2O2 in the transcriptional control of the gadd45a gene
through a Fenton-like free radical mechanism.
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Introduction
Inorganic arsenic is a ubiquitous environmental contaminant associated with a
multitude of adverse health effects, including hyperkeratosis, hyperpigementation,
diabetes mellitus, cardiovascular disease, reproductive defects, and cancers of several
tissues including liver, bladder, skin, lung, kidney, and prostate [1-17]. The most
common route of arsenic exposure is the ingestion of contaminated drinking water, which
has been documented in many countries at concentrations as high as 3.4 mg/L; more than
3000 times the World Health Organization recommended limits of 10 μg/L [18-23]. In
the United States, more than 56 million Americans are estimated to have been exposed to
drinking water containing arsenic concentrations that elevate the fatal cancer risk [24].
Although arsenic is poorly mutagenic in rodent and bacterial models, it has been
shown to cause DNA adduct formation, DNA-protein crosslinking, and the formation of
reactive oxygen species (ROS) in vitro [25-27]. In addition, arsenic has been shown to
induce an assortment of signaling events including NF-κB activation, AP-1 activation, cmyc overexpression, involucrin repression, and extracellular signal-regulated kinase
(ERK) activation, which are involved in such diverse processes as DNA repair, cellular
differentiation, cell cycle arrest, and malignant transformation [28-32]. Together, these
findings suggest that arsenic may be exerting its carcinogenic effects through an
epigenetic mechanism.
Cell cycle dysregulation and/or perturbation is a major mechanism of
carcinogenesis. While the signaling pathways involved in the G1/S phase checkpoint
have been well examined, much less is known about the signaling events that occur at the
G2/M phase checkpoint. Previous data from our lab and others have suggested that
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arsenic treatment can induce G2/M phase growth arrest in several different cell lines [3336]. A major player in G2/M arrest is the growth arrest and DNA damage-inducible
protein 45α (GADD45α), which is induced by a variety of stress-induced signals
including methyl methanesulfonate (MMS), ultraviolet (UV) irradiation, ionizing
radiation (IR), sodium arsenite exposure, and serum starvation [37-42]. In addition,
GADD45α is proposed to play roles in chromatin remodeling and apoptosis [43,44].
Transcription of the gadd45a gene is thought to be controlled by both the
promoter region and the third intron region and seems to be differentially activated
depending on the stimulus [45]. For example, in response to IR, the p53 transcription
factor binds to its consensus sequence site in the third intron of the gadd45a gene and
subsequently interacts with the WT1 transcription factor to enhance gene expression [46].
However, several groups have also suggested that after MMS and UV exposure, the
ubiquitous Oct-1 transcription factor binds the promoter region between -101 and -82
base pairs (bp) relative to the transcriptional start site (tss) of the gadd45a gene with the
help of an unidentified cofactor to activate gadd45a transcription in a p53-independent
manner [47-50]. Recently, the forkhead transcription factor family member FOXO3a,
has also been shown to bind to the forkhead response elements (FHREs) located in the
gadd45a gene promoter region at -505, -377, and -803 in response to UV, resulting in
transcriptional activation [51]. Thus, gadd45a gene regulation is complex and may
involve many different signaling pathways.
Since GADD45α is a general stress response protein, we examined the effects of
ROS produced in response to As(III) exposure on gadd45a gene regulation. We used a
human bronchial epithelial airway cell line, BEAS-2B, to examine these effects because
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the lung is a target of arsenic induced carcinogenesis, particularly in occupational settings
[7]. Our results show that As(III) transcriptionally induces gadd45a gene expression
from its promoter region via a free radical mechanism involving the formation of H2O2.

Materials and Methods
Cell Culture and Media.
The BEAS-2B human lung epithelial cell line was obtained from the American Type
Culture Collection (Manasses, VA) and maintained in Dulbecco’s Modified Eagle
Medium (Sigma, St. Louis, MO) containing 5% fetal bovine serum (Invitrogen/Gibco
BRL, Carlsbad, CA), 1 unit/mL penicillin, 1 μg/mL streptomycin, and 300 μg/mL Lglutamine (Sigma, St. Louis, MO). BEAS-2B cells were passaged when confluency was
reached, usually every 4-5 days.

Western Blotting.
Six well tissue culture plates were grown to a density of approximately 1 x 106 cells per
well and treated with concentrations of AsCl3 (Sigma, St. Louis, MO) ranging from 0-50
μM over a time period of 0-24 hours. Phosphate buffered saline (PBS) washed cells were
incubated five minutes with 100 μL of MPER mammalian lysis reagent (Pierce
Biotechnology, Inc., Rockford, IL) with shaking at room temperature. A portion of each
sample’s cell lysate (25 μL) was subsequently analyzed for total protein concentration
using a BCA Protein Assay kit (Pierce Biotechnology, Inc., Rockford, IL). Pre-cast 420% gradient polyacrylamide gels (Invitrogen, Carlsbad, CA) were loaded with 20 μg of
total protein for each sample and electrophoresis was perfomed for approximately 105
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minutes at 125 volts using a 1X dilution of 10X Tris-Glycine Running Buffer
(Invitrogen, Carlsbad, CA), the XCell SureLock Mini-Cell system (Invitrogen, Carlsbad,
CA), and a PowerPac 300 power supply (Bio-Rad Laboratories, Hercules, CA). Gels
were rinsed with a 1X dilution of 25X Tris-Glycine Transfer Buffer (Invitrogen,
Carlsbad, CA) and transferred to a PVDF membrane (Invitrogen, Carlsbad, CA) at 35
volts for two hours using the XCell II Blot Module (Invitrogen, Carlsbad, CA). PVDF
membranes were blocked for 1 hour at room temperature with 5% milk buffer in TBSTween (Sigma, St. Louis, MO). Membranes were incubated with a 1:200 dilution of
GADD45α (H-165) primary antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA)
in 5% milk buffer overnight at 4º C on a rocking platform. For β-actin primary antibody
(Sigma, St. Louis, MO) and GAPDH primary antibody (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA), dilutions of 1:2000 and 1:200 were used, respectively. Membranes
were subjected to three ten minute washes with TBS-Tween (Sigma, St. Louis, MO) and
immediately placed in a 1:1000 dilution of an anti-rabbit or anti-mouse IgG AP-linked
secondary antibody (Cell Signaling Technology, Beverly, MA) in 5% milk buffer for 2-4
hours at room temperature with shaking. After three ten minute washes with TBS-Tween
(Sigma, St. Louis, MO), membranes were immediately incubated with CDP-Star Reagent
(New England BioLabs, Inc., Beverly, MA) for five minutes with shaking in the dark at
room temperature. Membranes were rinsed with TBS-Tween and exposed to X-ray film
(Daigger, Vernon Hills, IL).

Oxygen Consumption.
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A Gilson 5/6 Oxygraph (Gilson Medical Electronics, Inc., Middleton, WI) was used to
perform oxygen consumption studies. BEAS-2B cells were trypsinized and washed with
1X PBS (Invivtrogen/Gibco BRL, Carlsbad, CA) and 4 x 106 cells were re-suspended in a
final volume of 1 mL of PBS. 1mM AsCl3 (Sigma, St. Louis, MO) was added to each
aliquot and allowed to incubate for 20 minutes at room temperature. Oxygen
consumption rates were calculated using the following equation:

nmoles O2 consumed/minute/106 cells = (BP – 47) ΔB (1.835) ,
(m)(t)(n)

where BP = atmospheric pressure in mmHg, ΔB = number of vertical blocks traversed
on the oxygraph chart paper (rise of experimental slope), m = slope of O2 standards (409
in this case), t = time in minutes used to determine ΔB (run of experimental slope), and n
= n x 106 cells used in the assay. Three replicates of three different samples were
averaged together to determine mean O2 consumption and error bars equal ± standard
error of the mean (SEM).

Electron Spin Resonance (ESR).
1 x 106 BEAS-2B cells were suspended in 500 μL of 1X PBS (Invitrogen/Gibco BRL,
Carlsbad, CA) and treated with 1 mM AsCl3 (Sigma, St. Louis, MO) and/or 2000 U/mL
catalase isolated from bovine liver (Sigma, St. Louis, MO). All ESR measurements were
conducted using a Bruker EMX spectrometer (Bruker Instruments Inc. Billerica, MA)
and a flat cell assembly. Hyperfine couplings were measured (to 0.1 G) directly from
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magnetic field separation using potassium tetraperoxochromate (K3CrO8) and 1,1diphenyl-2-picrylhydrazyl (DPPH) as reference standards. The relative radical
concentration was estimated by multiplying half of the peak height by (ΔHpp)2, where
ΔHpp represents peak-to peak width. The Acquisit program was used for data acquisitions
and analyses. Reactants were mixed in test tubes in a final volume of 1.0 mL. The
reaction mixture was then transferred to a flat cell for ESR measurement. The
concentrations given in the figure legends are final concentrations. Experiments were
performed at room temperature and under ambient air. Statistical analysis was performed
using Student’s t-test and error bars equal ± SEM.

Construction of GPx1-EGFP and SOD1-EGFP fusion constructs.
pcDNA3.1(+)/GPx1 and pcDNA3/SOD1 constructs were graciously provided to our
laboratory by Dr. Larry Oberley’s lab at the University of Iowa [52,53]. The GPx1
cDNA was removed from the pcDNA3.1 construct using a BamHI (Promega Life
Sciences, Madison, WI) and HindIII (Promega Life Sciences, Madison, WI) double
enzymatic digest. The SOD1 cDNA was removed from the pcDNA3 constuct using a
KpnI (Promega Life Sciences, Madison, WI) and ApaI (Promega Life Sciences, Madison,
WI) double enzymatic digest. Both GPx1 and SOD1 cDNA fragments were isolated
from an agarose gel and ligated into a pEGFP-C3 (BD Biosciences – Clontech, Palo Alto,
CA) vector in frame with the EGFP protein. Contents of both vectors were verified by
DNA sequencing (Biotech Core, Inc., Mountain View, CA).

Transient transfections.
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Transient transfections were performed using SuperFect Transfection Reagent (Qiagen,
Inc., Valencia, CA) according to the manufacturer’s instructions. Briefly, cells were
plated at 50% confluency, and DNA/SuperFect complexes were allowed to enter BEAS2B cells for three hours. DNA complexes were removed and fresh growth medium was
added. Transfection efficiencies of the pEGFP-C3, pEGFP-C3/GPx1, and pEGFPC3/SOD1 were calculated by counting EGFP (+) cells with a confocal microscope and
determined to be roughly 8-10% for all three plasmids.

Quantitative real- time polymerase chain reaction (qRT-PCR).
Total RNA was isolated from approximately 1 x 106 BEAS-2B cells using an RNeasy
Mini Kit (Qiagen, Inc., Valencia, CA). Total RNA was quantified using a NanoDrop
ND-1000 UV-Vis Spectrophotometer (NanoDrop Technologies, Wilmington, DE).
Quantitect SYBR Green one-step qRT-PCR kits (Qiagen, Inc., Valencia, CA) were used
to set up qRT-PCR reactions using 10 ng of total RNA as a template. qRT-PCR
experiments were performed on an ABI 7700 qRT-PCR machine (Applied Biosystems,
Foster City, CA). Validated GADD45α primer sets were obtained from Qiagen, Inc.
(Valencia, CA) and 18S rRNA primer set controls were obtained from Ambion, Inc.
(Austin, TX). Each sample was replicated three times per plate and an average ΔCt value
was calculated. Relative quantitation of GADD45α mRNA was calculated using the
ΔΔCt method. Error bars represent ± SEM.

Dual-Luciferase Reporter Assay.

143

BEAS-2B cells were applied to 12-well tissue culture plates at approximately 50%
confluency and transiently transfected with either a full length or deleted GADD45α
promoter-firefly luciferase construct (kind gifts from Dr. Dennis Bruemmer at the
University of California – Los Angeles, CA) or a GADD45α intron 3- firefly luciferase
construct (a kind gift from Dr. Albert J. Fornace, Jr. at Harvard University, Cambridge,
MA) [54,55]. In addition, each sample was co-transfected with a pRL-TK Renilla
luciferase vector (Promega Life Sciences, Madison, WI) underneath the constitutive
control of the herpes simplex virus thymidine kinase promoter to provide a measure of
transfection efficiency for normalization. Constructs were allowed to express for at least
60 hours followed by a 12 hour treatment with 25 μM AsCl3 (Sigma, St. Louis, MO).
100 μL of firefly luciferase substrate was injected into each well of a Lumitrac 200 96well plate (USA Scientific, Inc., Ocala, FL) containing 20 μL of cell lysate. Firefly
luciferase units were measured by an EG&G Berthold Microplate Luminometer
MicroLumat Plus with an automatic injector (EG&G Berthold, Germany). WinGlow
software (EG&G Berthold, Germany) was used to obtain readings with a 2.0 second
delay and a 10.0 second measurement of luciferase activity and expressed in luciferase
units. Luciferase substrates were obtained from the Dual-Luciferase Reporter Assay kit
(Promega Life Sciences, Madison, WI). Three replicates were assayed per experiment
and the ratio of inducible firefly luciferase activity to basal Renilla luciferase activity was
averaged for each group. Fold induction was calculated by dividing the average ratios of
As(III)-treated samples by the average ratios of samples left untreated. Error bars
represent ± SEM and statistical significance was calculated using Student’s t-test. Data
shown is representative of three independent experiments.
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Results
As(III) exposure induces expression of the GADD45α protein in a time- and dosedependent manner. Because GADD45α expression has been observed in response to
many stress conditions including UV irradiation, serum starvation, and alkylating agents,
we investigated the effects of As(III) exposure on its induction [32,37,38]. In order to
simulate airway exposure to arsenic, an immortalized non-tumorigenic BEAS-2B human
lung airway epithelial cell line was used for these experiments. Western blot analysis of
GADD45α in response to increasing concentrations of AsCl3 revealed a time- and dosedependent increase in protein abundance (Fig. 1), whereas equal concentrations of NaCl
had no effect (data not shown). β-actin abundance remained unaffected throughout the
dose and time course of As(III) exposure. Densitometry readings, normalized to β-actin
expression, confirmed that GADD45α protein abundance increased more than 100-fold
over untreated BEAS-2B cells 12 hours after 25 μM As(III ) treatment (data not shown).
This result demonstrates that GADD45α protein is induced in BEAS-2B cells in response
to As(III) exposure in a dose-dependent manner.

As(III) exposure increases oxygen consumption and ˙OH production in BEAS-2B
cells. Since As(III) has been shown to exert mutagenic effects via reactive oxygen
species (ROS) production in several cellular systems, it is possible that the signaling
events induced by As(III), specifically GADD45α induction, are also mediated by a ROS
mechanism [56]. In order to address this possibility, BEAS-2B cells were exposed to 1
mM As(III) for 20 minutes and the rate of oxygen consumption was measured by a
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Gilson 5/6 Oxygraph. As(III)-exposed BEAS-2B cells showed approximately a threefold increase in the amount of oxygen consumed in vitro (Fig. 2A), suggesting that a free
radical mechanism may be occurring in BEAS-2B cells upon As(III) stimulation.
To determine the identity of the radicals produced, we employed electron spin
resonance (ESR) spectroscopy. Representative ESR spectra are displayed in Figure 2B.
A basal level of ˙OH, signified by its 1-2-2-1 relative peak height fingerprint, is produced
by normal BEAS-2B cells, and was expected as a consequence of normal respiration;
however, after a 20 minute exposure to 1mM As(III), the ˙OH signal significantly
increased (Fig. 2B). Spectral results were quantified by peak height measurements in
Figure 2C, where a 2.5- fold increase in ˙OH production was observed after As(III)
exposure when compared to normal respiring cells. The ˙OH signal was attenuated by
the addition of 2000 units/mL of catalase, showing that H2O2 is a precursor of ˙OH.
These data indicate that ˙OH is a major free radical formed in the BEAS-2B cell line in
response to As(III) exposure.

GADD45α protein abundance decreases in response to As(III) in the presence of the
H2O2 scavenger, GPx1. Because As(III) produced ˙OH in the BEAS-2B cell line and
GADD45α is induced in response to many stressors, we hypothesized that its induction
may occur through an oxidative stress mechanism. To assess the role of ROS in
GADD45α induction, we constructed glutathione peroxidase 1 (GPx1)-EGFP and
superoxide dismutase 1 (SOD1)-EGFP overexpression/fusion vectors and examined their
effects on GADD45α protein abundance. The GPx1 enzyme is a H2O2 scavenger,
whereas the SOD1 enzyme is a O2˙- scavenger. GPx1-EGFP, SOD1-EGFP, and empty
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vector pEGFP-C3 constructs were transiently transfected into BEAS-2B cells. 48 hours
after transfection, cells were treated with 25 μM As(III) for 12 hours, and subjected to
Western blot analysis. Overexpression of the GPx1-EGFP fusion construct reduced
GADD45α protein abundance by at least 50% (Fig. 3) as measured by densitometry and
normalized to GAPDH expression (data not shown). Empty vector and SOD1 construct
overexpression did not affect GADD45α expression (Fig. 3), implying that the formation
of H2O2 is partially responsible for the induction of the GADD45α protein in response to
As(III).

As(III) exposure increases GADD45α mRNA abundance. To determine how As(III)
exposure induces the GADD45α protein, we examined GADD45α transcript abundance
at several time points using qRT-PCR. A concentration of 25 μM As(III) was chosen to
obtain a maximal effect. Relative quantification of GADD45α mRNA was performed
using the 0 hour time point as a calibration value. As shown in Figure 4, GADD45α
mRNA increases almost 30-fold after three hours of treatment. Although GADD45α
mRNA slightly decreased during the following three time points, it began to increase
again at the 24 hour time point, mimicking the GADD45α protein expression pattern (see
Fig.1). Therefore, we reasoned that the gadd45α gene could be transcriptionally induced
by As(III) exposure.

As(III) activates transcription of gadd45α through both the promoter region and the
third intron region. To establish whether the increase in mRNA abundance resulted
from transcriptional activation or as a consequence of increased mRNA stability, we
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examined the effects of As(III) on induction of the gadd45α promoter and intron 3
regions. GADD45α promoter-luciferase and intron 3-luciferase transcriptional fusion
constructs were transiently transfected into BEAS-2B cells, subjected to As(III) treatment
for 12 hours, and assayed for luciferase activity. The GADD45α promoter construct
showed a five-fold increase in luciferase activity in response to 25 μM As(III) (Fig. 5).
Similarly, the GADD45α intron 3 construct exhibited a four-fold increase in activity (Fig.
5). Neither of the control constructs containing the luciferase gene alone (GVB2 or GL3)
showed any discernible difference between the untreated samples and the As(III)-exposed
samples, illustrating that both the promoter and intron 3 regions of the gadd45a gene are
activated by As(III) exposure.
Since H2O2 was involved in As(III)-induced GADD45a protein levels, we
examined the effects of H2O2 on the transcriptional activation of gadd45a. GPx1 or a
control vector was co-transfected with the aforementioned GADD45α promoter and
intron 3 constructs. GPx1 overexpression decreased promoter-luciferase activity by 50%
when compared to transfection with the empty vector (Fig. 6). Surprisingly, the control
vector itself slightly increased luciferase activity in the gadd45a promoter construct. The
reason for this phenomenon is unclear. In contrast, the activity of the intron 3 construct
after As(III) exposure remained largely unaffected (Fig. 6). These results suggest a role
for H2O2 in the transcriptional activation of the gadd45a promoter region.

As(III) activation of the GADD45α promoter region occurs between -81 and -234
relative to the tss. Given that the GADD45α promoter-luciferase transcriptional fusion
construct was activated by the presence of H2O2, we wanted to pinpoint which portion of
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the promoter region was responsible for the activation. Six GADD45α promoterluciferase deletion constructs, named for the length of the promoter region with regards to
the transcriptional start site (+1), were transfected into BEAS-2B cells and exposed to 25
μM As(III) for 12 hours (Fig. 7A). A five- to six- fold increase in luciferase activity was
observed in all constructs containing at least 234 base pairs upstream of the +1 site (Fig.
7B). A further deletion of approximately 150 bp (to -81) eliminated most of the
luciferase activity. Putative transcription factor binding sites located in this region
include consensus sequences for AP-1, MBF-1, Egr-1, Egr-2, Egr-3, and WT1 (-KTS)
[57].
We subsequently examined the effects of As(III)-induced H2O2 formation on the
induction of the promoter deletion constructs. Again, GPx1 overexpression and the
removal of H2O2 decreased luciferase induction by approximately 50% in all constructs
showing more than five-fold induction (Fig. 7C). No change was seen in the smaller
constructs. These results suggest that the 153 bp region located between -234 and -81
contains an As(III)-responsive region that is sensitive to the production of H2O2.

Discussion
The findings presented here suggest that As(III) exposure induces the
transcriptional activation of the gadd45a gene through a Fenton-like free radical
mechanism (Fig. 8). The Fenton reaction, which is usually associated with an excess of
Fe(II), occurs when a transition metal is oxidized during its interaction with H2O2,
producing an oxidized metal and two molecules of ˙OH. Our data show that As(III)
treatment increases the amount of molecular oxygen consumed by BEAS-2B cells,
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indicating that more oxygen is available for conversion to O2˙- and subsequent formation
of H2O2. In addition, ESR data shows that the relative amount of ˙OH increases in
response to As(III) exposure, which is alleviated by treatment with the H2O2 scavenger
enzyme catalase. The removal of H2O2 from the intracellular environment by GPx1
overexpression decreases gadd45a promoter-luciferase activity and GADD45α protein
expression, further supporting a role for H2O2 in GADD45α induction. Surprisingly,
treatment with H2O2 alone only weakly induced GADD45α protein expression when
compared to equal concentrations of As(III) treatment, whereas co-treatment with H2O2
and As(III) enhanced GADD45α protein induction (data not shown). Collectively, these
results suggest that the formation of ˙OH through a Fenton-like reaction is at least
partially responsible for the induction of gadd45a transcription and protein expression in
response to As(III) exposure.
The induction of gadd45a transcription by the production of H2O2 and/or ˙OH and
each molecule’s subsequent intracellular activities may partially account for the wide
variety of chemical and physical inducers of GADD45α protein expression. IR and UV
irradiation, both potent inducers of GADD45α expression, also induce ˙OH formation
[37,58]. Additionally, generation of H2O2 and ˙OH via the Fenton reaction can induce
the formation of apurinic sites, the same type of DNA lesion induced by another potent
GADD45α inducer, methyl methanesulfonate (MMS) [37,59]. These data suggest that
H2O2 and/or ˙OH production may be a key regulator of GADD45α transcriptional
induction.
Because, BEAS-2B cells contain a p53 protein that has been inactivated by
expression of the E6 viral protein, gadd45a transcriptional activation by As(III) occurs
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through a p53-independent mechanism in these cells [60]. Based on the experimental
data presented in this manuscript, we have identified several other candidate transcription
factors that may be involved in gadd45a transcription. One major candidate is the AP-1
transcription factor, since it has previously been identified as an As(III)-activated protein
[61,62]. In addition, the yeast homolog of the human AP-1 protein, Yap1, contains a
redox regulated domain consisting of disulfide bonds that can mask or expose its nuclear
localization sequence, depending on the redox status of the cell [63]. These findings
make AP-1 an ideal candidate for ROS-mediated transcriptional activation. Moreover,
the 153 bp region of the gadd45a promoter-luciferase deletion constructs affected by
antioxidant overexpression boasts four possible AP-1 consensus binding sequences [57].
Finally, AP-1 has also been identified as the transcription factor responsible for
increasing expression of the DNA damage response gene gadd153 after As(III) exposure,
suggesting that H2O2 production and redox status may be a general mechanism for the
transcriptional activation of DNA damage response genes [64].
Alternatively, the early growth response 1 (Egr-1) transcription factor may also be
involved in H2O2-mediated transcriptional activation of gadd45a. Egr-1 has recently
been shown to induce gadd45a transcription in response to UV irradiation [65].
Furthermore, Egr-1 induction occurs three hours after 25 μM As(III) treatment
coincidental with the increase in gadd45a mRNA abundance shown in Fig. 4 (D. Bhatia
and F. Chen, unpublished data). Testing is underway in our laboratory to determine the
effects of Egr-1 on gadd45a transcriptional activation in response to As(III) exposure.
In conclusion, we have shown that the gadd45a gene is transcriptionally induced
by As(III) exposure through the formation of H2O2. This induction occurs in the
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promoter region of the gadd45a gene and the redox responsive element is located in the 234 to -81 base pair region. Future work will focus on the identification of the
transcription factor(s) responsible for the oxidative stress-dependent transcriptional
induction of gadd45a.
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List of Abbreviations:
GADD45α

growth arrest and DNA damage-inducible protein 45 alpha

H2O2

hydrogen peroxide

As(III)

arsenite

bp

base pairs

tss

transcriptional start site

mg

milligram

μg

microgram

L

liter

DNA

deoxyribonucleic acid

ROS

reactive oxygen species

NF-κB

nuclear factor κB

AP-1

activator protein 1

ERK

extracellular signal-regulated kinase

G1/S

gap 1/synthesis phase checkpoint

G2/M

gap2/mitosis phase checkpoint

MMS

methylmethane sulfonate

UV

ultraviolet irradiation

IR

ionizing radiation

FHRE

forkhead response elements

mL

milliliter

AsCl3

arsenic trichloride

μM

micromolar

153

μL

microliter

PBS

phosphate buffered saline

μg

microgram

PVDF

Polyvinylidene fluoride

TBS-Tween

Tris-buffered saline

O2

oxygen

SEM

standard error of the mean

mM

millimolar

ESR

electron spin resonance

G

Gauss

DPPH

diphenyl-2-picrylhydrazyl

K3CrO8

potassium tetraperoxochromate

GPx1

glutathione peroxidase 1

SOD1

superoxide dismutase 1

cDNA

complementary DNA

EGFP

enhanced green fluorescence protein

qRT-PCR

quantitative real-time polymerase chain reaction

RNA

ribonucleic acid

rRNA

ribosomal ribonucleic acid

Ct

threshold cycle

˙OH

hydroxyl radical

O2˙-

superoxide radical

GAPDH

Glyceraldehyde-3-phosphate dehydrogenase
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mRNA

messenger ribonucleic acid

MBF-1

metal binding factor 1

Egr-1

early growth response gene 1

Egr-2

early growth response gene 2

Egr-3

early growth response gene 3

Yap1

yeast activator protein 1

gadd153

growth arrest and DNA damage-inducible protein 153
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Figure Legends:
Fig. 1. 25 μM As(III) induces maximal GADD45α expression at 12 hours.
A dose/time course Western blot of As(III)-exposed BEAS-2B cells show
maximal GADD45α induction after 12 hours of treatment. BEAS-2B cells were
exposed to As(III) concentrations of 0, 3.25, 6.25, 12.5, 25, and 50 μM. 20 μg
of total protein were loaded into each lane and GADD45α expression was
detected with a polyclonal antibody.
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Fig. 2. A. As(III) exposure increases O2 consumption in BEAS-2B cells.
Aliquots of 4 x 106 BEAS-2B cells were injected into a Gilson 5/6 Oxygraph
and the rate of oxygen consumption was measured with or without a 20 minute exposure
to 1mM As(III). O2 consumption in the presence of As(III) was increased approximately
three fold.
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Figure 2B. As(III) induces the formation of •OH in BEAS-2B cells. Formation of •OH
was measured by ESR spectroscopy in aliquots of 1 x 106 BEAS-2B cells with or without
exposure to 1mM As(III). Figures shown are examples of spectra of control BEAS-2B
cells (left) and As(III)-exposed BEAS-2B cells (right) exhibiting the characteristic ˙OH
ESR fingerprint.
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Figure 2C. Graphical representation of ESR peak height. ESR peak heights were
measured and quantified as described in Materials and Methods. As(III)-exposed BEAS2B cells showed a 2.5 fold increase in the amount of •OH formation which was abrogated
by the addition of 2000 units/mL of catalase, confirming the identity of •OH.
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Fig. 3. Overexpression of the H2O2 scavenging enzyme GPx1 reduces GADD45α
protein expression. BEAS-2B cells were transiently transfected with a GPx1, SOD1, or
C3 empty vector and assayed for changes in GADD45α expression via western blot.
Removal of H2O2 by GPx1 overexpression decreased GADD45α expression by
approximately 50%.
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Fig. 4. As(III) exposure increases GADD45α transcript abundance. Relative
qRT-PCR was employed to measure the abundance of the GADD45α transcript using the
0 hr time point as a calibrator. Transcript abundance increased approximately 30 fold
after a three hour As(III) treatment.
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Fig. 5. As(III) activates both the GADD45α promoter region and the intron 3 region.
A dual luciferase reporter system was used to determine the activation of the GADD45α
promoter-luciferase (G45) and the intron 3-luciferase (Int3) constructs. Constructs were
transiently transfected into BEAS-2B cells and luciferase activity was normalized to an
internal transfection control. 5.2 and 4 fold increases in the G45 and Int3 luciferase
activity, respectively, were observed in As(III)-exposed samples when compared to the
untreated control samples.
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Fig. 6. Overexpression of GPx1 reduces GADD45α promoter activation,
but not intron 3 activation. G45 and Int3 luciferase constructs were transiently
co-transfected with either an empty vector or the vector overexpressing the GPx1 protein
and exposed to 25 μM As(III) or left untreated. GPx1 overexpression decreased the G45
promoter luciferase activity by 50%, but seemed to have no effect on Int3 activity.
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Fig. 7A. Schematic diagram of GADD45α promoter-luciferase deletion constructs.
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Fig. 7B. GADD45α promoter activation occurs between the -234 and -81 region. The
effects of As(III) on the activation of GADD45α promoter luciferase deletion constructs
were examined after a 12 hour treatment period with 25 μM As(III). The full length (2552), -1326, -817, and -234 constructs all retained an induction of approximately 5-6
fold when exposed to arsenic, whereas the -81 construct showed a loss of activation by
As(III).
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Fig. 7C. Activation of the full length, -1326, -817, and -234 constructs was reduced by
50% in GPx1-overexpressing cell lysates.
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Fig. 8. Proposed ROS pathway involving arsenic. The proposed ROS pathway
responsible for the activation of the gadd45a promoter region is a Fenton-like reaction in
which molecular oxygen accepts an electron, forming O2˙-, and is then converted to H2O2
by superoxide dismutase. H2O2 is then further broken down into water and molecular
oxygen, unless the presence of a transition metal, such as As(III), is present. Excess
As(III) can then react with H2O2 and produce ˙OH, which leads to DNA damage, lipid
peroxidation, and the activation of cellular signaling pathways, including the induction of
gadd45a transcription.

167

References

[1] Balasoiu, C. F.; Zagury, G. J.; Deschenes, L. Partitioning and speciation of
chromium, copper, and arsenic in CCA-contaminated soils: influence of soil
composition. Sci. Total Environ. 280:239-255; 2001.
[2] Stephanopoulos, D. E.; Willman, D. A.; Shevlin, D.; Pinter, L.; Gummin, D. D.
Treatment and toxicokinetics of acute pediatric arsenic ingestion: danger of arsenic
insecticides in children. Pediatr. Crit. Care Med. 3:74-80; 2002.
[3] Bailey, E. J.; Kennaway, E. L.; Urquhart, M. E. Arsenic content of cigarettes. Br. J.
Cancer 11:49-53; 1957.
[4] Das, H. K.; Mitra, A. K.; Sengupta, P. K.; Hossain, A.; Islam, F.; Rabbani, G. H.
Arsenic concentrations in rice, vegetables, and fish in Bangladesh: a preliminary study.
Environ. Int. 30: 383-387; 2004.
[5] Haque, R.; Mazumder, D. N.; Samanata, S.; Ghosh, N.; Kalman, D.; Smith, M. M.;
Mitra, S.; Santra, A.; Lahiri, S.; Das, S.; De, B. K.; Smith, A. H. Arsenic in drinking
water and skin lesions: dose-response data from West Bengal, India. Epidemiology
14:174-182; 2003.
[6] Roychowdhury, T.; Uchino, T.; Tokunaga, H.; Ando, M. Arsenic and other heavy
metals in soils from an arsenic-affected area of West Bengal, India. Chemosphere
49:605-618; 2002.
[7] Axelson, O.; Dahlgren, E.; Jansson, C. D.; Rehnlund, S. O. Arsenic exposure and
mortality: a case-referent study from a Swedish copper smelter. Br. J. Ind. Med 35:8-15;
1978.

168

[8] Smith, A. H.; Lingas, E. O.; Rahman, M. Contamination of drinking-water by
arsenic in Bangladesh: a public health emergency. Bull. World Health Organ. 78:10931103; 2000.
[9] Centeno, J. A.; Mullick, F. G.; Martinez, L.; Page, N. P.; Gibb, H.; Longfellow, D.;
Thompson, C.; Ladich, E. R. Pathology related to chronic arsenic exposure. Environ.
Health Perspect. 110 Supp 5: 883-886; 2002.
[10] Chen, C. J.; Chuang, Y. C.; Lin, T. M.; Wu, H. Y. Malignant neoplasms among
residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water
and cancers. Cancer Res. 45:5895-5899; 1985.
[11] Chen, C. J.; Hsueh, Y. M.; Lai, M. S.; Shyu, M. P.; Chen, S. Y.; Wu, M. M.; Kuo,
T. L.; Tai, T. Y. Increased prevalence of hypertension and long-term arsenic exposure.
Hypertension 25:53-60; 1995.
[12] International Agency for Research on Cancer (IARC). Carcinogenesis of arsenic
compounds. IARC Monograph on Evaluation of Carcinogenic Risks 23:37-141; 1980.
[13] Leonard, A.; Lauwerys, R. R. Carcinogenicity, teratogenicity, and mutagenicity of
arsenic. Mutat. Res. 75:49-62; 1980.
[14] Mabuchi, K.; Lilienfeld, A. M.; Snell, L. M. Lung cancer among pesticide workers
exposed to inorganic arsenicals. Arch. Environ. Health 34:312-320; 1979.
[15] Pinto, S. S.; Nelson, K. W. Arsenic toxicology and industrial exposure. Annu. Rev.
Pharmacol. Toxicol. 16:95-100; 1976.
[16] Pinto, S. S.; Enterline, P. E.; Henderson, V.; Varner, M. O. Mortality experience in
relation to a measured arsenic trioxide exposure. Environ. Health Perspect. 19:127-130;
1977.

169

[17] Steinmaus, C.; Moore, L.; Hopenhayn-Rich, C.; Biggs, M. L.; Smith, A. H. Arsenic
in drinking water and bladder cancer. Cancer Invest. 18:174-182; 2000.
[18] World Health Organization (WHO). Arsenic in Drinking Water. Fact Sheet No.
210 Geneva: WHO Press; 2001.
[19] National Research Council (NRC). Arsenic in Drinking Water. Washington, D.C.:
National Academy Press; 1999.
[20] Klaassen, C. D.; Amdur, M. O.; Doull, J. Cassarett and Doull’s Toxicology: The
Basic Sciences of Poisons. New York: McGraw-Hill; 1996.
[21] Bagla, P.; Kaiser, J. India’s spreading health crisis draws global arsenic experts.
Science 274: 174-175; 1996.
[22] Lewis, D. R.; Southwick, J. W.; Ouellet-Hellstrom, R.; Rench, J.; Calderon, R. L.
Drinking water arsenic in Utah: A cohort mortality study. Environ. Health Perspect.
107: 359-365; 1999.
[23] Nordstrom, D. K. Public health. Worldwide occurrences of arsenic in ground water.
Science 296: 2143-2145; 2002.
[24] Natural Resources Defense Council (NRDC). Arsenic and old laws: a scientific and
public health analysis of arsenic occurrence in drinking water, its health effects, and
EPA’s outdated arsenic tap water standard.
http://www.nrdc.org/water/drinking/arsenic/chap1.asp
[25] Rossman, T. G.; Stone, D.; Molina, M.; Troll, W. Absence of arsenite mutagenicity
in E. coli and Chinese hamster cells. Environ. Mutagen. 2: 371-379; 1980.
[26] Germolec, D. R.; Spalding, J.; Boorman, G. A.; Wilmer, J. L.; Yoshida, T.;
Simeonova, P. P.; Bruccoleri, A.; Kayama, F.; Gaido, K.; Tennant, R.; Burleson, F.;

170

Dong, W.; Lang, R. W.; Luster, M. I. Arsenic can mediate skin neoplasia by chronic
stimulation of keratinocyte-derived growth factors. Mutat. Res. 386: 209-218; 1997.
[27] Germolec, D. R.; Spalding, J.; Yu, H.S.; Chen, G. S.; Simeonova, P. P.; Humble, M.
C.; Bruccoleri, A.; Boorman, G. A.; Foley, J. F.; Yoshida, T.; Luster, M. I. Arsenic
enhancement of skin neoplasia by chronic stimulation of growth factors. Am. J. Pathol.
153: 1775-1785; 1998.
[28] Kachinskas, D. J.; Philips, M. A.; Qin, Q.; Stokes, J. D.; Rice, R. H. Arsenate
perturbation of human keratinocyte differentiation.. Cell Growth Diff. 5: 1235-1241;
1994.
[29] Huang, C.; Ma, W. Y.; Li, J.; Goranson, A.; Dong, Z. Requirement of Erk, but not
JNK, for arsenite-induced cell transformation. J. Biol. Chem. 274: 14595-14601; 1999.
[30] Chen, F.; Zhang, Z.; Leonard, S. S.; Shi, X. Contrasting roles of NF-kappaB and
JNK in arsenite-induced p53-independent expression of GADD45alpha. Oncogene 20:
3585-3589; 2001.
[31] Wijeweera, J. B.; Gandolfi, A. J.; Parrish, A.; Lantz, R. C. Sodium arsenite
enhances AP-1 and NFkappaB DNA binding and induces stress protein expression in
precision-cut rat lung slices. Toxicol. Sci. 61: 283-294; 2001.
[32] Chen, F.; Lu, Y.; Zhang, Z.; Vallyathan, V.; Ding, M.; Castranova, V.; Shi, X.
Opposite effect of NF-kappaB and c-Jun N-terminal kinase on p53-independent
GADD45 induction by arsenite. J. Biol. Chem. 276: 11414-11419; 2001.
[33] Yih, L.H., Hsueh, S.W., Luu, W.S., Chiu, T.H., Lee, T.C. Arsenite induces
prominent mitotic arrest via inhibition of G2 checkpoint activation in CGL-2 cells.
Carcinogenesis 26: 53-63; 2005.

171

[34] Chen, F., Zhang, Z., Bower, J., Lu, Y., Leonard, S.S., Ding, M., Castranova, V.,
Piwinica-Worms, H., Shi, X. Arsenite-induced Cdc25C degradation is through the KENbox and ubiquitin-proteosome pathway. Proc. Natl. Acad. Sci. U.S.A. 99: 1990-1995;
2002.
[35] Park, W.H., Seol, J.G., Kim, E.S., Hyun, J.M., Jung, C.W., Lee, C.C., Kim, B.K.,
Lee, Y.Y. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via
cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21,
and apoptosis. Cancer Res. 60: 3065-3071; 2000.
[36] Seol, J.G., Park, W.H., Kim, E.S., Jung, C.W., Hyun, J.M., Kim, B.K., Lee, Y.Y.
Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1.
Biochm. Biophys. Res. Commun. 265; 400-404.
[37] Fornace, A. J. Jr.; Nebert, D. W.; Hollander, M. C.; Luethy, J. D.; Papathanasiou,
M.; Fargnoli, J.; Holbrook, N. J. Mammalian genes coordinately regulated by growth
arrest signals and DNA-damaging agents. Mol. Cell. Biol. 9: 4196-4203; 1989.
[38] Yih, L. H.; Peck, K.; Lee, T. C. Changes in gene expression profiles of human
fibroblasts in response to sodium arsenite treatment. Carcinogenesis 23: 867-876; 2002.
[39] Andrew, A. S.; Warren, A. J.; Barchowsky, A.; Temple, K. A.; Klei, L.; Soucy, N.
V.; O’Hara, K. A.; Hamilton, J. W. Genomic and proteomic profiling of responses to
toxic metals in human lung cells. Environ. Health Perspect. 111: 825-835; 2003.
[40] Zhan, Q.; Antinore, M. J.; Wang, X. W.; Carrier, F.; Smith, M. L.; Harris, C. C.;
Fornace, A. J. Jr. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase
activity by the p53-regulated protein Gadd45. Oncogene 18: 2892-2900; 1999.

172

[41] Wang, X. W.; Zhan, Q.; Coursen, J. D.; Khan, M. A.; Kontny, H. U.; Yu, L.;
Hollander, M. C.; O’Conner, P. M.; Fornace, A. J. Jr.; Harris, C. C. GADD45 induction
of a G2/M cell cycle checkpoint. Proc. Natl. Acad. Sci. U. S. A. 96: 3706-3711; 1999.
[42] Mak, S. K.; Kultz, D. Gadd45 proteins induce G2/M arrest and modulate apoptosis
in kidney cells exposed to hyperosmotic stress. J. Biol. Chem. 279: 39075-39084; 2004.
[43] Carrier, F.; Georgel, P. T.; Pourquier, P.; Blake, M.; Kontny, H. U.; Antinore, M. J.;
Gariboldi, M.; Myers, T. G.; Weinstein, J. N.; Pommier, Y.; Fornace, A. J. Jr. Gadd45, a
p53-responsive stress protein, modifies DNA accessibility on damaged chromatin. Mol.
Cell. Biol. 19: 1673-1685; 1999.
[44] Kastan, M. B.; Zhan, Q.; el-Deiry, W. S.; Carrier, F.; Jacks, T.; Walsh, W. V.;
Plunkett, B. S.; Vogelstein, B.; Fornace, A. J. Jr. A mammalian cell cycle checkpoint
pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587597; 1992.
[45] Graunke, D. M.; Fornace, A. J. Jr.; Pieper, R. O. Presetting of chromatin structure
and transcription factor binding poise the human GADD45 gene for rapid transcriptional
up-regulation. Nucleic Acids Res. 27: 3881-3890; 1999.
[46] Zhan, Q.; Chen, I. T.; Antinore, M. J.; Fornace, A. J. Jr. Tumor suppressor p53 can
participate in transcriptional induction of the GADD45 promoter in the absence of direct
DNA binding. Mol. Cell. Biol. 18: 2768-2778; 1998.
[47] Takahashi, S.; Satio, S.; Ohtani, N.; Sakai, T. Involvement of the Oct-1 regulatory
element of the gadd45 promoter in the p53-independent response to ultraviolet
irradiation. Cancer Res. 61: 1187-1195; 2001.

173

[48] Jin, S.; Fan, F.; Fan, W.; Zhao, H.; Tong, T.; Blanck, P.; Alomo, I.; Rajasekaran, B.;
Zhan, Q. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction
of the GADD45 following DNA damage. Oncogene 20: 2683-2690; 2001.
[49] Zhao, H.; Jin, S.; Fan, F.; Fan, W.; Tong, T.; Zhan, Q. Activation of the
transcription factor Oct-1 in response to DNA damage. Cancer Res 60: 6276-6280;
2000.
[50] Daino, K.; Ichimura, S.; Nenoi, M. Comprehensive search for x-ray-responsive
elements and binding factors in the regulatory region of the GADD45a gene. J. Radiat.
Res. (Tokyo). 44: 311-318; 2003.
[51] Tran, H.; Brunet, A.; Grenier, J. M.; Datta, S. R.; Fornace, A. J. Jr.; DiStefano, P.
S.; Chiang, L. W.; Greenberg, M. E. DNA repair pathway stimulated by the forkhead
transcription factor FOXO3a through the GADD45 protein. Science 296: 530-534;
2002.
[52] Li, S.; Yan, T.; Yang, J. Q.; Oberley, T. D.; Oberley, L. W. The role of cellular
glutathione peroxidase redox regulation in the suppression of tumor cell growth by
manganese superoxide dismutase. Cancer Res. 60: 3927-3939; 2000.
[53] Zhang, Y.; Zhao, W.; Zhang, H. J.; Domann, F. E.; Oberley, L. W. Overexpression
of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res.
62: 1205-1212; 2002.
[54] Bruemmer, D., Yin, F., Liu, J., Berger, J.P., Sakai, T., Blaschke, F., Fleck, E., Van
Herle, A.J., Forman, B.M., Law, R.E. Regulation of the growth arrest and DNA damageinducible gene 45 (GADD45) by peroxisome proliferators-activated receptor gamma in
vascular smooth muscle cells. Circ. Res. 93: e38-47; 2003.

174

[55] Zhan, Q., Chen, I.T., Antinore, M.J., Fornace, A.J. Jr. Tumor suppressor p53 can
participate in transcriptional induction of the GADD45 promoter in the absence of direct
DNA binding. Mol. Cell. Biol. 18; 2768-2778; 1998.
[56] Hei, T. K.; Liu, S. X.; Waldren, C. Mutagenicity of arsenic in mammalian cells:
role of reactive oxygen species. Proc. Natl. Acad. Sci. U. S. A. 95: 8103-8107; 1998.
[57] Schug, J.; Overton, G. C. TESS: Transcription Element Search Software on the
WWW'. Technical Report CBIL-TR-1997-1001-v0.0. Computational Biology and
Informatics Laboratory, School of Medicine, University of Pennsylvania; 1997.
http://www.cbil.upenn.edu/tess

[58] Halliwell, B.; Gutteridge, J. M. C. Free Radicals in Biology and Medicine. New
York: Oxford University Press, Inc.; 1999.
[59] Nakamura, J., La, D.K., Swenberg, J.A. 5’-nicked apurinic/apyrimidinic sites are
resistant to β-elimination by β-polymerase and are persistent in human cultured cells after
oxidative stress. J. Biol. Chem. 275: 5323-5328; 2000.
[60] Reddel, R.R., Ke, Y., Gerwin, B.I., McMenamin, M.G., Lechner, J.F., Su, R.T.,
Brash, D.E., Park, J.B., Rhim, J.S., Harris, C.C. Transformation of human bronchial
epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or
transfection via strontium phosphate coprecipitation with a plasmid containing SV40
early region genes. Cancer Res. 48: 1904-1909; 1988.
[61] Cavigelli, M.; Li, W. W.; Lin, A.; Su, B.; Yoshioka, K.; Karin, M. The tumor
promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J.
15: 6269-6279; 1996.
[62] Simeonova, P. P.; Wang, S.; Toriuma, W.; Kommineni, V.; Matheson, J.; Unimye,
N.; Kayama, F.; Harki, D.; Ding, M.; Vallyathan, V.; Luster, M. I. Arsenic mediates cell
175

proliferation and gene expression in the bladder epithelium: association with activating
protein-1 transactivation. Cancer Res. 60: 3445-3453; 2000.
[63] Wood, M. J.; Storz, G.; Tjandra, N. Structural basis for redox regulation of Yap1
transcription factor localization. Nature 430: 917-921 ; 2004.
[64] Guyton, K. Z.; Xu, Q.; Holbrook, N. J. Induction of the mammalian stress response
gene GADD153 by oxidative stress: role of AP-1 element. Biochem. J. 314: 547-554;
1996.
[65] Thyss, R., Virolle, V., Imbert, V., Peyron, J.F., Aberdam, D., Virolle, T. NFκB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal
cell death. EMBO J. 24: 128-137; 2005.

176

OVERALL CONCLUSIONS
1. Gene-environment interactions are an integral part of environmental-induced
carcinogenesis. The elucidation of the human genome sequence and new
techniques that have emerged will play a major role in understanding the
molecular mechanisms underlying the carcinogenic action of environmental
contaminants.
2. Metal exposure is a major contributor to environmental induced carcinogenesis.
Each metal produces its own effects, and these effects are different for each cell
type. Identification of each individual mechanism of metal-induced
carcinogenesis is necessary in order to obtain effective treatments.
3. Arsenite produces hydroxyl radical in the BEAS-2B cell line.
4. Arsenite induces GADD45α in a dose- and time-dependent manner.
5. Arsenite can eleveate hydrogen peroxide and/or hydroxyl radical production and
subsequently GADD45α protein levels in the BEAS-2B cell line.
6. Arsenite induces hydrogen peroxide-mediated GADD45α transcription.
7. A 153 base pair region of the GADD45 promoter is regulated by As(III)induced hydrogen peroxide formation.
8. Arsenite induces GADD45α expression in a p53-independent manner in the
BEAS-2B cell line.
9. The transcriptional induction of the gadd45a gene by arsenite seems to occur
through a Fenton-like reaction mechanism.

177

Jacquelyn Bower
jbower@alumni.nd.edu
Home Address
742 Ridgeway Avenue
Morgantown, WV 26505
(304) 685-9514
Education

Business Address
1095 Willowdale Rd, MS2015
Morgantown, WV 26505
(304) 285-6372

West Virginia University, Morgantown, WV
Department of Basic Pharmaceutical Sciences
PhD Candidate
University of Notre Dame, Notre Dame, IN
Bachelor of Science, May 2001
Major: Biological Sciences

Honors
And Awards

Sigma Xi Graduate Research Competition Winner (2005)
Basic Pharmaceutical Sciences Departmental Teaching Award (2005)
West Virginia University Van Liere Convocation Research Award (2004)
Basic Pharmaceutical Sciences Departmental Graduate Research Award (2003)
Oak Ridge Institute for Science & Education Fellowship (2002)
Centers for Disease Control and Prevention Regular Fellowship (2001 – present)
University of Notre Dame Dean's Honor List (2001)
National Science Foundation Fellowship (2000)
University of Notre Dame Scholar (1997)
Robert C. Byrd Honors Scholarship (1997)

Presentations

Invited Speaker – Chinese Academy of Sciences, Institute for Nutritional Sciences, 2005,
Shanghai, China A Graduate Education at West Virginia University
Invited Speaker – 3rd International Conference on the Molecular Mechanisms of Metal
Toxicity and Carcinogenesis, 2004, Morgantown, WV As(III)Induction of the Growth Arrest and DNA Damage-inducible protein 45α
Invited Speaker – West Virginia University Van Liere Convocation, 2004, Morgantown,
WV The Role of GADD45α in G2/M Phase Arrest
Graduate Research Association of Students in Pharmacy, 2004, Atlanta, GA The
Role of GADD45α in G2/M Phase Arrest
Allegheny Erie Society of Toxicology Spring Meeting, 2003, Pittsburgh, PA GADD45α
is an Oxidative Stress Response Protein
Experimental Biology, 2003, San Diego, CA GADD45α is an Oxidative Stress Response
Protein

Professional
Activities

Invited Reviewer for Neurotoxicology and Teratology (2004)
American Association for the Advancement of Science (AAAS) – Member 2004-present
Association for Women in Science – West Virginia University Chapter (AWIS) –
Treasurer 2004 - 2005
American Physiological Society (APS) – Member 2003-present
Served as an experimental consultant for researchers at the Chinese Academy of Sciences
Institute for Nutritional Sciences, West Virginia University, and the National
Institute for Occupational Safety and Health
Student Representative - Graduate Research Advisory Council (2003 – 2004)

178

Research
Experience

CENTERS FOR DISEASE CONTROL AND PREVENTION-NIOSH, Morgantown, WV
PhD Candidate, Xianglin Shi, PhD, September 2001-Present
• Currently conducting independent research involving reactive oxygen species and
the effects of arsenic on the induction of the GADD45α pathway and its role in cell
cycle arrest.
THE JACKSON LABORATORY, Bar Harbor, ME
Participant, November 7-13, 2003
• Participated in the “Short Course on Gene Microarray Development and Analysis:
Approaches to Heart, Lung, Blood, and Sleep Disorders.”
• Designed, prepared, and analyzed microarray experimental data.
CENTERS FOR DISEASE CONTROL AND PREVENTION-NIOSH, Morgantown,
WV
Biological Research Technician, Xianglin Shi, PhD, May 2001 – September 2001
• Conducted independent research regarding the regulatory role of nuclear
transcription factor NF-κB and the G2/M phase cell-cycle checkpoint protein,
GADD45α.
UNIVERSITY OF NOTRE DAME, Notre Dame, IN
Lab Assistant, Jeffrey Schorey, PhD, October 1998 – May 2001
• Conducted undergraduate research in microbiology, immunology, and molecular
biology including isolation and purification of a complement activating
mycobacterial surface glycolipid.
• Cloned retroviral constructs for subsequent transduction of primary murine
bone marrow macrophages.
UNIVERSITY OF NOTRE DAME, Notre Dame, IN
NSF Fellowship, Crislyn D’Souza-Schorey, PhD, Summer 2000
• Conducted undergraduate research in cell biology, including the effects of ARF6
on mycobacterial pathogenesis by retroviral expression of ARF6 in primary murine
bone marrow macrophages.
WASHINGTON UNIVERSITY, St. Louis, MO
Lab Assistant, Frederik Lindberg, MD/PhD, Summer 1999
• Conducted undergraduate research in immunology, including production of
antigens to make monoclonal antibodies to hSIRPα1, an NK surface receptor
molecule responsible for recognition of CD47 on red blood cells.

Teaching
Experience

KAPLAN TEST PREP, INC., Pittsburgh, PA
Teacher, Steven Danyluk, Center Manager, March 2002 – November 2005
• Presented lectures to prepare Kaplan students for standardized testing including the
MCAT, GRE, DAT, SAT, and ACT.
• Privately tutored students for the MCAT, GRE, and SAT.
WEST VIRGINIA UNIVERSITY, Morgantown, WV
Teaching Assistant Coordinator, Joseph Ma, PhD, September 2004 – December 2004
Teaching Assistant, Joseph Ma, PhD, September 2003- May 2004
• Organized and managed a group of ten teaching assistants
• Delegated general laboratory duties to ensure that laboratory exercises were executed
in an efficient manner.
• Provided laboratory assistance to first year pharmacy students learning basic
research techniques.
• Prepared lectures to guide students in the concepts behind laboratory exercises.

179

UNIVERSITY OF NOTRE DAME, Notre Dame, IN
Teaching Assistant, Michelle Whaley, PhD, January 2001-May 2001
• Guided and assisted second year students conducting independent research projects.

Lab Skills

Biological Research Techniques:
• Molecular: western blotting, protein purification, standard cloning, 2DE,
quantitative RT-PCR, immunoprecipitation, flow cytometry, ELISA, luciferase
reporter gene assays, and site-directed mutagenesis.
• General & Technical: Tissue culture, mouse manipulations, HPLC, TLC, oxygen
consumption, ESR, and confocal microscopy.

Publications Bower, J.J., Leonard, S.S., Chen, F., and Shi, X. As(III) transcriptionally
activates the gadd45a gene via the formation of H2O2. (submitted)
Bower, J.J., Leonard, S.S., and Shi, X. (2005) Conference overview:
Molecular mechanisms of metal toxicity and carcinogenesis. Mol Cell
Biochem 279:3-15
Bower, J.J. and Shi, X. (2005) Environmental health research in the
post-genomic sequencing era: New fields, new challenges, and new
opportunities. J Toxicol Environ Health B Crit Rev 8:71-94
Leonard, S.S., Bower, J.J., and Shi, X. (2004) Conference overview:
Metal-induced toxicity, carcinogenesis, mechanisms and cellular
responses. Mol Cell Biochem 255:3-10
Chen, F., Zhang, Z., Bower, J., Lu, Y., Leonard, S.S., Ding, M.,
Castranova, V., Piwnica-Worms, H., and Shi, X. (2002) Arsenite-Induced
Cdc25C Degradation is through the KEN-box and Ubiquitin-Proteasome
Pathway. Proc Natl Acad Sci USA 99:1990-5
Chen, F., Bower, J., Leonard, S.S., Ding, M., Lu, Y., Rojanasakul, Y.,
Kung, H.H., Vallyathan, V., Castranova, V., and Shi, X. (2002) Protective
Roles of NF-kappa B for Chromium(VI)-induced Cytotoxicity Is Revealed
by Expression of Ikappa B Kinase-beta Mutant. J Biol Chem 277:33423349.
Chen, F., Bower, J., Demers, L.M., Shi, X. (2001) Upstream Signal
Transduction of NF-kB Activation. Atlas Genet Cytogenet Oncol
Haematol December.
URL :
http://www.infobiogen.fr/services/chromcancer/Deep/NFKBID20033.html
Bohlson, S. S., Strasser, J.A., Bower, J.J., and Schorey, J.S. (2001) Role
of Complement in Mycobacterium avium Pathogenesis: In Vivo and In
Vitro Analyses of the Host Response to Infection in the Absence of
Complement Component C3. Infect Immun 69:7729-7735.

180

